XM_040189480.1	chrI	3248545	3248545	chrI	3246957	3258999	-	XM_040189480.1	path1	Q9MYX0	Sodium-dependent serotonin transporter	5HT transporter;Solute carrier family 6 member 4;	 PF03491;PF00209;	 GO:0012505;GO:0010008;GO:0005925;GO:0005887;GO:0045121;GO:0043005;GO:0005886;GO:0098793;GO:0045202;GO:0051015;GO:0042802;GO:0046872;GO:0005326;GO:0050998;GO:0051378;GO:0005335;GO:0048854;GO:0071310;GO:0046621;GO:0045787;GO:0010628;GO:0090067;GO:0009636;GO:0051610;GO:0035176;GO:0035725;	  C:endomembrane system; C:endosome membrane; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:presynapse; C:synapse;	  F:actin filament binding; F:identical protein binding; F:metal ion binding; F:neurotransmitter transmembrane transporter activity; F:nitric-oxide synthase binding; F:serotonin binding; F:serotonin:sodium symporter activity;	  P:brain morphogenesis; P:cellular response to organic substance; P:negative regulation of organ growth; P:positive regulation of cell cycle; P:positive regulation of gene expression; P:regulation of thalamus size; P:response to toxic substance; P:serotonin uptake; P:social behavior; P:sodium ion transmembrane transport;
XM_040174847.1	chrI	26604719	26604719	chrI	26526347	26680230	-	XM_040174847.1	path1	O15394 A8MQ06 B7Z841 Q7Z7F2	Neural cell adhesion molecule 2		 PF00041;PF07679;	 GO:0030424;GO:0016021;GO:0043005;GO:0016604;GO:0005886;GO:0042802;GO:0007413;GO:0007158;GO:0007608;	  C:axon; C:integral component of membrane; C:neuron projection; C:nuclear body; C:plasma membrane;	  F:identical protein binding;	  P:axonal fasciculation; P:neuron cell-cell adhesion; P:sensory perception of smell;
XM_040167321.1	chrII	8245408	8245408	chrII	8240052	8325974	+	XM_040167321.1	path1	P78333 B2R726 O60436 Q9BX27	Glypican-5		 PF01153;	 GO:0046658;GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0005796;GO:0016021;GO:0043202;GO:0005886;GO:0016477;GO:0006024;GO:0006027;GO:0090263;GO:1905475;GO:0001523;	  C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:plasma membrane;	 	  P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:positive regulation of canonical Wnt signaling pathway; P:regulation of protein localization to membrane; P:retinoid metabolic process;
XM_040164547.1	chrII	8361771	8361771	chrII	8335561	8432963	-	XM_040164547.1	path1	Q5RE54	Glypican-6		 PF01153;	 GO:0046658;GO:0062023;GO:0005615;GO:0016477;GO:0009966;	  C:anchored component of plasma membrane; C:collagen-containing extracellular matrix; C:extracellular space;	 	  P:cell migration; P:regulation of signal transduction;
XM_040170451.1	chrIII	2161292	2161292	chrIII	2153033	2163959	-	XM_040170451.1	path1	Q5VZ46 Q5VZ45 Q9HCF8	Uncharacterized protein KIAA1614		 PF15737;	 GO:0016324;GO:0005938;GO:0005634;GO:0005080;GO:0007098;GO:0007163;GO:0060341;	  C:apical plasma membrane; C:cell cortex; C:nucleus;	  F:protein kinase C binding;	  P:centrosome cycle; P:establishment or maintenance of cell polarity; P:regulation of cellular localization;
XM_040170453.1	chrIII	2161356	2161356	chrIII	2164111	2179317	+	XM_040170453.1	path1	Q4VGL6 B2RS13 Q69Z31	Roquin-1 {ECO:0000305}	Protein Sanroque {ECO:0000303|PubMed:23583642};RING finger and C3H zinc finger protein 1;RING finger and CCCH-type zinc finger domain-containing protein 1;	 PF18386;PF00642;PF13445;	 GO:0005737;GO:0010494;GO:0000932;GO:0003725;GO:0035198;GO:0003730;GO:0003729;GO:0035613;GO:0061630;GO:0004842;GO:0008270;GO:0061158;GO:0001782;GO:0071347;GO:0048535;GO:0046007;GO:0030889;GO:0002635;GO:2000320;GO:0045623;GO:0000956;GO:0000288;GO:0033962;GO:0061014;GO:1901224;GO:0010608;GO:0000209;GO:0010468;GO:0002634;GO:2000628;GO:0043488;GO:0050856;GO:0048536;GO:0043029;GO:0042098;GO:0050852;GO:0061470;GO:0006511;	  C:cytoplasm; C:cytoplasmic stress granule; C:P-body;	  F:double-stranded RNA binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA stem-loop binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;	  P:3'-UTR-mediated mRNA destabilization; P:B cell homeostasis; P:cellular response to interleukin-1; P:lymph node development; P:negative regulation of activated T cell proliferation; P:negative regulation of B cell proliferation; P:negative regulation of germinal center formation; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of T-helper cell differentiation; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:P-body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of NIK/NF-kappaB signaling; P:posttranscriptional regulation of gene expression; P:protein polyubiquitination; P:regulation of gene expression; P:regulation of germinal center formation; P:regulation of miRNA metabolic process; P:regulation of mRNA stability; P:regulation of T cell receptor signaling pathway; P:spleen development; P:T cell homeostasis; P:T cell proliferation; P:T cell receptor signaling pathway; P:T follicular helper cell differentiation; P:ubiquitin-dependent protein catabolic process;
XM_040171825.1	chrIII	2318001	2318001	chrIII	2295392	2372855	+	XM_040171825.1	path1	P78333 B2R726 O60436 Q9BX27	Glypican-5		 PF01153;	 GO:0046658;GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0005796;GO:0016021;GO:0043202;GO:0005886;GO:0016477;GO:0006024;GO:0006027;GO:0090263;GO:1905475;GO:0001523;	  C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:plasma membrane;	 	  P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:positive regulation of canonical Wnt signaling pathway; P:regulation of protein localization to membrane; P:retinoid metabolic process;
XM_040171021.1	chrIII	3041462	3041462	chrIII	3007497	3121393	+	XM_040171021.1	path1	Q6PFX6	Cadherin-24		 PF00028;PF01049;	 GO:0005912;GO:0016342;GO:0005911;GO:0016021;GO:0045294;GO:0008013;GO:0045296;GO:0005509;GO:0070097;GO:0034332;GO:0016339;GO:0000902;GO:0098609;GO:0098742;GO:0007043;GO:0007156;GO:0007275;	  C:adherens junction; C:catenin complex; C:cell-cell junction; C:integral component of membrane;	  F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:calcium ion binding; F:delta-catenin binding;	  P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development;
XM_040170797.1	chrIII	7223409	7223409	chrIII	7216370	7227089	+	XM_040170797.1	path1	Q8N350 K7EJP2 O43385	Voltage-dependent calcium channel beta subunit-associated regulatory protein {ECO:0000305}		 	 GO:0030426;GO:0016021;GO:0005886;GO:0030141;GO:0030672;GO:0044325;GO:1903170;GO:0045955;GO:1901386;	  C:growth cone; C:integral component of membrane; C:plasma membrane; C:secretory granule; C:synaptic vesicle membrane;	  F:ion channel binding;	  P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of voltage-gated calcium channel activity;
XM_040170816.1	chrIII	7223409	7223409	chrIII	7227539	7238726	-	XM_040170816.1	path1	Q0GGW5	Serine/threonine-protein kinase STK11 {ECO:0000250|UniProtKB:Q15831}	Liver kinase B1 homolog;	 PF00069;	 GO:0005737;GO:0005829;GO:0016020;GO:0005739;GO:0005634;GO:0005524;GO:0000287;GO:0002039;GO:0030295;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0007050;GO:0006974;GO:0009267;GO:0030010;GO:0042593;GO:0072332;GO:0090090;GO:0030308;GO:0046777;GO:0006470;GO:0006468;GO:0001558;GO:0042493;GO:0010212;GO:0001944;	  C:cytoplasm; C:cytosol; C:membrane; C:mitochondrion; C:nucleus;	  F:ATP binding; F:magnesium ion binding; F:p53 binding; F:protein kinase activator activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:activation of protein kinase activity; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to starvation; P:establishment of cell polarity; P:glucose homeostasis; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:protein autophosphorylation; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of cell growth; P:response to drug; P:response to ionizing radiation; P:vasculature development;
XM_040171547.1	chrIII	7293905	7293905	chrIII	7291648	7296093	+	XM_040171547.1	path1	Q90WG1	Spindlin-Z		 PF02513;	 GO:0005634;GO:0007049;GO:0007276;	  C:nucleus;	 	  P:cell cycle; P:gamete generation;
XM_040171546.1	chrIII	7293905	7293905	chrIII	7291652	7296093	+	XM_040171546.1	path1	Q4V8J7	Spindlin-1	Spindlin1;	 PF02513;	 GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:0003677;GO:0035064;GO:0006325;GO:0007276;GO:0051321;GO:0007275;GO:0045893;GO:0030177;GO:0006355;GO:0009303;GO:0016055;	  C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;	  F:DNA binding; F:methylated histone binding;	  P:chromatin organization; P:gamete generation; P:meiotic cell cycle; P:multicellular organism development; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription, DNA-templated; P:rRNA transcription; P:Wnt signaling pathway;
XM_040171019.1	chrIII	7400399	7400399	chrIII	7378655	7391994	-	XM_040171019.1	path1	O95948	One cut domain family member 2	Hepatocyte nuclear factor 6-beta;One cut homeobox 2;Transcription factor ONECUT-2;	 PF02376;PF00046;	 GO:0015629;GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0009887;GO:0045165;GO:0060271;GO:0031018;GO:0002064;GO:0001889;GO:0030512;GO:0048935;GO:0030335;GO:0045944;GO:0001952;GO:0006357;	  C:actin cytoskeleton; C:chromatin; C:nucleoplasm; C:nucleus;	  F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:animal organ morphogenesis; P:cell fate commitment; P:cilium assembly; P:endocrine pancreas development; P:epithelial cell development; P:liver development; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peripheral nervous system neuron development; P:positive regulation of cell migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell-matrix adhesion; P:regulation of transcription by RNA polymerase II;
XM_040170668.1	chrIII	7401473	7401473	chrIII	7410835	7433212	+	XM_040170668.1	path1	Q01978 Q5D0A6	Transcription factor E2-alpha	Transcription factor 3;Transcription factor XE12/XE47;	 PF00010;	 GO:0005634;GO:0043425;GO:0003700;GO:0000981;GO:0070888;GO:0046982;GO:0030154;GO:0007399;GO:0045666;GO:0045944;	  C:nucleus;	  F:bHLH transcription factor binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:protein heterodimerization activity;	  P:cell differentiation; P:nervous system development; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II;
XM_040170658.1	chrIII	7499887	7499887	chrIII	7485338	7491861	-	XM_040170658.1	path1	Q90705	Elongation factor 2		 PF00679;PF14492;PF03764;PF00009;PF03144;	 GO:0005737;GO:1990904;GO:0005525;GO:0003924;GO:0043022;GO:0003746;GO:0006414;	  C:cytoplasm; C:ribonucleoprotein complex;	  F:GTP binding; F:GTPase activity; F:ribosome binding; F:translation elongation factor activity;	  P:translational elongation;
XM_040170673.1	chrIII	7499887	7499887	chrIII	7494488	7499547	+	XM_040170673.1	path1	Q91XE9 Q8BWS0	Cyclic AMP-responsive element-binding protein 3-like protein 3	Transcription factor CREB-H;	 PF00170;	 GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005654;GO:0005634;GO:0035497;GO:0001228;GO:0000981;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:0000976;GO:0030968;GO:0045944;GO:1990440;GO:0006357;	  C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:nucleus;	  F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;	  P:endoplasmic reticulum unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II;
XM_040172046.1	chrIII	7499887	7499887	chrIII	7502262	7504787	+	XM_040172046.1	path1	Q9NSD7 Q14DA5	Relaxin-3 receptor 1	G protein-coupled receptor SALPR;G-protein coupled receptor GPCR135;Relaxin family peptide receptor 3;Somatostatin- and angiotensin-like peptide receptor;	 PF00001;	 GO:0005887;GO:0005886;GO:0008528;GO:0004930;GO:0007186;GO:0007218;GO:0032467;	  C:integral component of plasma membrane; C:plasma membrane;	  F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity;	  P:G protein-coupled receptor signaling pathway; P:neuropeptide signaling pathway; P:positive regulation of cytokinesis;
XM_040172047.1	chrIII	7499887	7499887	chrIII	7506046	7512245	-	XM_040172047.1	path1	Q8N6T7 B2RCD0 O75291 Q6IAF5 Q6PK99 Q8NCD2 Q9BSI5 Q9BWP3 Q9NRC7 Q9UQD1	NAD-dependent protein deacetylase sirtuin-6	Regulatory protein SIR2 homolog 6;SIR2-like protein 6;	 PF02146;	 GO:0099115;GO:0005737;GO:0005654;GO:0005634;GO:0019213;GO:0004407;GO:0003956;GO:0003950;GO:0070403;GO:0017136;GO:0046969;GO:0003714;GO:0008270;GO:0070932;GO:0000122;GO:1905555;GO:1902732;GO:0031940;GO:0120162;GO:1905549;GO:0032206;GO:1901485;GO:1905564;GO:0003247;GO:0006471;GO:0006476;GO:0010569;GO:0031667;	  C:chromosome, subtelomeric region; C:cytoplasm; C:nucleoplasm; C:nucleus;	  F:deacetylase activity; F:histone deacetylase activity; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:transcription corepressor activity; F:zinc ion binding;	  P:histone H3 deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of blood vessel branching; P:positive regulation of chondrocyte proliferation; P:positive regulation of chromatin silencing at telomere; P:positive regulation of cold-induced thermogenesis; P:positive regulation of subtelomeric heterochromatin assembly; P:positive regulation of telomere maintenance; P:positive regulation of transcription factor catabolic process; P:positive regulation of vascular endothelial cell proliferation; P:post-embryonic cardiac muscle cell growth involved in heart morphogenesis; P:protein ADP-ribosylation; P:protein deacetylation; P:regulation of double-strand break repair via homologous recombination; P:response to nutrient levels;
XM_040172048.1	chrIII	7534357	7534357	chrIII	7518201	7522744	+	XM_040172048.1	path1	F1Q8W0 A1L232	Cactin		 PF10312;PF09732;	 GO:0005737;GO:0005681;GO:0008595;GO:0001654;GO:0045087;GO:0045292;GO:0045824;GO:0007399;GO:0003407;GO:0040019;GO:0010468;	  C:cytoplasm; C:spliceosomal complex;	 	  P:anterior/posterior axis specification, embryo; P:eye development; P:innate immune response; P:mRNA cis splicing, via spliceosome; P:negative regulation of innate immune response; P:nervous system development; P:neural retina development; P:positive regulation of embryonic development; P:regulation of gene expression;
XM_040172049.1	chrIII	7534357	7534357	chrIII	7522944	7529342	-	XM_040172049.1	path1	Q9YHX4	Semaphorin-4E	Semaphorin-7;Semaphorin-Z7;	 PF01437;PF01403;	 GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0010693;GO:0048843;GO:0000122;GO:0001755;GO:0043931;GO:0030335;GO:0043547;GO:0071526;	  C:extracellular space; C:integral component of plasma membrane;	  F:chemorepellent activity; F:semaphorin receptor binding;	  P:axon guidance; P:negative chemotaxis; P:negative regulation of alkaline phosphatase activity; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of transcription by RNA polymerase II; P:neural crest cell migration; P:ossification involved in bone maturation; P:positive regulation of cell migration; P:positive regulation of GTPase activity; P:semaphorin-plexin signaling pathway;
XM_040172054.1	chrIII	7534357	7534357	chrIII	7529646	7534343	-	XM_040172054.1	path1	Q9UGK3 A6NKK3 Q9NXI2	Signal-transducing adaptor protein 2	Breast tumor kinase substrate;	 	 GO:0005829;GO:0005886;GO:0035591;GO:0042531;	  C:cytosol; C:plasma membrane;	  F:signaling adaptor activity;	  P:positive regulation of tyrosine phosphorylation of STAT protein;
XM_040172051.1	chrIII	7534357	7534357	chrIII	7534649	7543634	-	XM_040172051.1	path1	Q8AXV0	Endophilin-A2	Endophilin-2;SH3 domain-containing GRB2-like protein 2;SH3p8;	 PF03114;PF00018;	 GO:0030054;GO:0042995;GO:0031901;GO:0002102;GO:0008289;GO:0006897;	  C:cell junction; C:cell projection; C:early endosome membrane; C:podosome;	  F:lipid binding;	  P:endocytosis;
XM_040172180.1	chrIII	7534357	7534357	chrIII	7544336	7556424	-	XM_040172180.1	path1	Q92753 Q8WX73	Nuclear receptor ROR-beta	Nuclear receptor RZR-beta;Nuclear receptor subfamily 1 group F member 2;Retinoid-related orphan receptor-beta;	 PF00104;PF00105;	 GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0008502;GO:0004879;GO:0000978;GO:1990837;GO:0008134;GO:0008270;GO:0035881;GO:0071300;GO:0042462;GO:0045668;GO:0045892;GO:0045944;GO:0045893;GO:0042752;GO:0006357;GO:0006355;GO:0060041;GO:0046549;GO:0046548;GO:0048511;GO:0006367;GO:0007601;	  C:chromatin; C:nucleoplasm; C:nucleus;	  F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:melatonin receptor activity; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:zinc ion binding;	  P:amacrine cell differentiation; P:cellular response to retinoic acid; P:eye photoreceptor cell development; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:retina development in camera-type eye; P:retinal cone cell development; P:retinal rod cell development; P:rhythmic process; P:transcription initiation from RNA polymerase II promoter; P:visual perception;
XM_040172186.1	chrIII	7549811	7549811	chrIII	7564006	7565723	+	XM_040172186.1	path1	Q9HC97 J3KR30 O43495 Q17R58 Q4VBN5 Q4ZFV2 Q6FHI8 Q86UH4	G-protein coupled receptor 35	Kynurenic acid receptor;	 PF00001;	 GO:0005887;GO:0005886;GO:0016494;GO:0004930;GO:0070098;GO:0007010;GO:0007186;GO:1904456;GO:1901386;GO:0007204;GO:0051482;GO:0035025;	  C:integral component of plasma membrane; C:plasma membrane;	  F:C-X-C chemokine receptor activity; F:G protein-coupled receptor activity;	  P:chemokine-mediated signaling pathway; P:cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:negative regulation of neuronal action potential; P:negative regulation of voltage-gated calcium channel activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of Rho protein signal transduction;
XM_040172177.1	chrIII	7562597	7562597	chrIII	7574165	7596301	-	XM_040172177.1	path1	O70141	Semaphorin-6B	Semaphorin-Z;	 PF01403;	 GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007417;GO:0021766;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;	  C:extracellular space; C:integral component of plasma membrane;	  F:chemorepellent activity; F:semaphorin receptor binding;	  P:axon guidance; P:central nervous system development; P:hippocampus development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;
XM_040170754.1	chrIII	15397381	15397381	chrIII	15358995	15388769	+	XM_040170754.1	path1	P24797	Sodium/potassium-transporting ATPase subunit alpha-2	Sodium pump subunit alpha-2;	 PF00689;PF00690;	 GO:0005737;GO:0016021;GO:0005886;GO:0005524;GO:0046872;GO:0005391;GO:0030007;GO:0006883;GO:0001504;GO:1990573;GO:1902600;GO:0006942;GO:0036376;	  C:cytoplasm; C:integral component of membrane; C:plasma membrane;	  F:ATP binding; F:metal ion binding; F:P-type sodium:potassium-exchanging transporter activity;	  P:cellular potassium ion homeostasis; P:cellular sodium ion homeostasis; P:neurotransmitter uptake; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of striated muscle contraction; P:sodium ion export across plasma membrane;
XM_040170755.1	chrIII	15397381	15397381	chrIII	15375463	15388769	+	XM_040170755.1	path1	P18907	Sodium/potassium-transporting ATPase subunit alpha-1	Na(+)/K(+) ATPase alpha-1 subunit;	 PF00689;PF00690;	 GO:0016324;GO:0016323;GO:0016021;GO:0016328;GO:0031090;GO:0005886;GO:0014069;GO:0005890;GO:0036126;GO:0030315;GO:0005524;GO:0051087;GO:0046872;GO:0005391;GO:0016791;GO:1990239;GO:0030007;GO:0071383;GO:0006883;GO:0086009;GO:0031947;GO:0045822;GO:0045823;GO:0045989;GO:1990573;GO:1902600;GO:0008217;GO:0002028;GO:0002026;GO:0042493;GO:1903416;GO:0036376;	  C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:lateral plasma membrane; C:organelle membrane; C:plasma membrane; C:postsynaptic density; C:sodium:potassium-exchanging ATPase complex; C:sperm flagellum; C:T-tubule;	  F:ATP binding; F:chaperone binding; F:metal ion binding; F:P-type sodium:potassium-exchanging transporter activity; F:phosphatase activity; F:steroid hormone binding;	  P:cellular potassium ion homeostasis; P:cellular response to steroid hormone stimulus; P:cellular sodium ion homeostasis; P:membrane repolarization; P:negative regulation of glucocorticoid biosynthetic process; P:negative regulation of heart contraction; P:positive regulation of heart contraction; P:positive regulation of striated muscle contraction; P:potassium ion import across plasma membrane; P:proton transmembrane transport; P:regulation of blood pressure; P:regulation of sodium ion transport; P:regulation of the force of heart contraction; P:response to drug; P:response to glycoside; P:sodium ion export across plasma membrane;
XM_040170759.1	chrIII	15397381	15397381	chrIII	15389908	15393561	+	XM_040170759.1	path1	P70097	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	Integral membrane protein CII-3;QPs-1;	 PF01127;	 GO:0016021;GO:0005743;GO:0005749;GO:0009055;GO:0020037;GO:0046872;GO:0000104;GO:0006099;	  C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone);	  F:electron transfer activity; F:heme binding; F:metal ion binding; F:succinate dehydrogenase activity;	  P:tricarboxylic acid cycle;
XM_040175423.1	chrIV	32584511	32584511	chrIV	32581888	32583675	-	XM_040175423.1	path1	Q90259	Achaete-scute homolog 1a	Pituitary-absent protein;	 PF00010;	 GO:0005634;GO:0090575;GO:0000981;GO:0046983;GO:0000977;GO:0043565;GO:0021984;GO:0031103;GO:0043697;GO:0048566;GO:0002070;GO:0021575;GO:0060575;GO:0010629;GO:0007399;GO:0030182;GO:0045666;GO:0045944;GO:0045893;GO:0031099;GO:0050767;GO:0006357;GO:0070654;GO:0007423;GO:0061549;GO:0061195;	  C:nucleus; C:RNA polymerase II transcription regulator complex;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;	  P:adenohypophysis development; P:axon regeneration; P:cell dedifferentiation; P:embryonic digestive tract development; P:epithelial cell maturation; P:hindbrain morphogenesis; P:intestinal epithelial cell differentiation; P:negative regulation of gene expression; P:nervous system development; P:neuron differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regeneration; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:sensory epithelium regeneration; P:sensory organ development; P:sympathetic ganglion development; P:taste bud formation;
XM_040175436.1	chrIV	32584511	32584511	chrIV	32586646	32593388	+	XM_040175436.1	path1	Q969R8 A8K4Z5 D3DUQ2 Q6PKU5 Q96SX6	KICSTOR complex protein ITFG2 {ECO:0000305}	Integrin-alpha FG-GAP repeat-containing protein 2 {ECO:0000312|HGNC:HGNC:30879};	 PF15907;	 GO:0005829;GO:0140007;GO:0005765;GO:0005654;GO:0034198;GO:0042149;GO:0002314;GO:1904262;GO:0032006;	  C:cytosol; C:KICSTOR complex; C:lysosomal membrane; C:nucleoplasm;	 	  P:cellular response to amino acid starvation; P:cellular response to glucose starvation; P:germinal center B cell differentiation; P:negative regulation of TORC1 signaling; P:regulation of TOR signaling;
XM_040175437.1	chrIV	32602258	32602258	chrIV	32595040	32608598	-	XM_040175437.1	path1	Q9JHR9 Q14BZ2 Q3U0V7 Q3UYH0	Nuclear receptor-interacting protein 2	Neuronal-interacting factor X 1;	 PF09668;	 GO:0005737;GO:0005634;GO:0004190;GO:0000122;GO:0007219;	  C:cytoplasm; C:nucleus;	  F:aspartic-type endopeptidase activity;	  P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway;
XM_040175432.1	chrIV	32602258	32602258	chrIV	32609787	32612863	-	XM_040175432.1	path1	Q8BFQ9 Q6ZPT4	Kelch-like protein 42	Cullin-3-binding protein 9;Kelch domain-containing protein 5;	 PF01344;	 GO:0031463;GO:0005737;GO:0005819;GO:0004842;GO:0007049;GO:0051301;GO:0043161;GO:0000209;GO:0032886;	  C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:spindle;	  F:ubiquitin-protein transferase activity;	  P:cell cycle; P:cell division; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of microtubule-based process;
XM_040174538.1	chrIV	32690154	32690154	chrIV	32671394	32680942	-	XM_040174538.1	path1	Q28C41	Vezatin		 PF12632;	 GO:0005912;GO:0016021;GO:0005634;GO:0005886;GO:0002142;GO:0017022;GO:0098609;	  C:adherens junction; C:integral component of membrane; C:nucleus; C:plasma membrane; C:stereocilia ankle link complex;	  F:myosin binding;	  P:cell-cell adhesion;
XM_040174757.1	chrIV	32690154	32690154	chrIV	32681801	32696421	+	XM_040174757.1	path1	Q6ZV73 Q6ZR53 Q7Z2Z7 Q96D44 Q9NUR8 Q9P2I5	FYVE, RhoGEF and PH domain-containing protein 6	Zinc finger FYVE domain-containing protein 24;	 PF01363;PF00169;PF00621;	 GO:0005737;GO:0005856;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;	  C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:lamellipodium; C:ruffle;	  F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;	  P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity;
XM_040173972.1	chrIV	32779885	32779885	chrIV	32767155	32772110	-	XM_040173972.1	path1	O55137 Q549A9	Acyl-coenzyme A thioesterase 1 {ECO:0000250|UniProtKB:Q86TX2}	CTE-I;Inducible cytosolic acyl-coenzyme A thioester hydrolase;Long chain acyl-CoA thioester hydrolase;Palmitoyl-coenzyme A thioesterase {ECO:0000250|UniProtKB:Q86TX2};	 PF08840;PF04775;	 GO:0005737;GO:0005829;GO:0005739;GO:0047617;GO:0052689;GO:0102991;GO:0016290;GO:0006637;GO:0006631;GO:0001676;GO:0010667;	  C:cytoplasm; C:cytosol; C:mitochondrion;	  F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:myristoyl-CoA hydrolase activity; F:palmitoyl-CoA hydrolase activity;	  P:acyl-CoA metabolic process; P:fatty acid metabolic process; P:long-chain fatty acid metabolic process; P:negative regulation of cardiac muscle cell apoptotic process;
XM_040173971.1	chrIV	32779885	32779885	chrIV	32767155	32772140	-	XM_040173971.1	path1	Q8BWN8 Q8BJQ1 Q8BL20 Q9QYR8	Peroxisomal succinyl-coenzyme A thioesterase {ECO:0000305|PubMed:16940157}	Acyl-coenzyme A thioesterase 4;PTE-2b;Peroxisomal acyl coenzyme A thioester hydrolase Ib;Peroxisomal long-chain acyl-CoA thioesterase Ib;	 PF08840;PF04775;	 GO:0005777;GO:0047617;GO:0052689;GO:0044466;GO:0004778;GO:0006637;GO:0043649;GO:0043648;GO:0006631;GO:0001676;GO:0032788;GO:0046459;GO:0006104;GO:0032789;GO:0000038;	  C:peroxisome;	  F:acyl-CoA hydrolase activity; F:carboxylic ester hydrolase activity; F:glutaryl-CoA hydrolase activity; F:succinyl-CoA hydrolase activity;	  P:acyl-CoA metabolic process; P:dicarboxylic acid catabolic process; P:dicarboxylic acid metabolic process; P:fatty acid metabolic process; P:long-chain fatty acid metabolic process; P:saturated monocarboxylic acid metabolic process; P:short-chain fatty acid metabolic process; P:succinyl-CoA metabolic process; P:unsaturated monocarboxylic acid metabolic process; P:very long-chain fatty acid metabolic process;
XM_040173973.1	chrIV	32779885	32779885	chrIV	32772105	32775753	+	XM_040173973.1	path1	Q95KK4	Single-stranded DNA-binding protein, mitochondrial		 PF00436;	 GO:0042645;GO:0003682;GO:0003697;GO:0006260;	  C:mitochondrial nucleoid;	  F:chromatin binding; F:single-stranded DNA binding;	  P:DNA replication;
XM_040173974.1	chrIV	32779885	32779885	chrIV	32776433	32793433	+	XM_040173974.1	path1	A1L224	Cyclic AMP-responsive element-binding protein 3-like protein 2		 PF00170;	 GO:0005783;GO:0005789;GO:0016021;GO:0005634;GO:0035497;GO:0000981;GO:0000976;GO:0051216;GO:0002062;GO:0030968;GO:0045944;GO:0060628;GO:0003330;GO:0006357;GO:0034976;	  C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus;	  F:cAMP response element binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:transcription regulatory region sequence-specific DNA binding;	  P:cartilage development; P:chondrocyte differentiation; P:endoplasmic reticulum unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of extracellular matrix constituent secretion; P:regulation of transcription by RNA polymerase II; P:response to endoplasmic reticulum stress;
XM_040187614.1	chrIX	871871	871871	chrIX	855692	903860	+	XM_040187614.1	path1	Q9R1L5 Q7TQG9 Q80TN0	Microtubule-associated serine/threonine-protein kinase 1	Syntrophin-associated serine/threonine-protein kinase;	 PF08926;PF17820;PF00069;	 GO:0030424;GO:0005737;GO:0005856;GO:0030425;GO:0016020;GO:0043005;GO:0043025;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0007420;GO:0007010;GO:0035556;GO:0018105;GO:0006468;	  C:axon; C:cytoplasm; C:cytoskeleton; C:dendrite; C:membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;	  F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:brain development; P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation;
XM_040187619.1	chrIX	908061	908061	chrIX	905367	912739	+	XM_040187619.1	path1	Q684M2	Cysteine protease ATG4D	Autophagin-4;Autophagy-related protein 4 homolog D;	 PF03416;	 GO:0005759;GO:0008234;GO:0006915;GO:0006914;GO:0015031;	  C:mitochondrial matrix;	  F:cysteine-type peptidase activity;	  P:apoptotic process; P:autophagy; P:protein transport;
XM_040187622.1	chrIX	911634	911634	chrIX	913920	928611	+	XM_040187622.1	path1	P51532 B1A8Z4 B1A8Z5 B1A8Z6 B1A8Z7 E9PBR8 O95052 Q9HBD3	Transcription activator BRG1	ATP-dependent helicase SMARCA4;BRG1-associated factor 190A;Mitotic growth and transcription activator;Protein BRG-1;Protein brahma homolog 1;SNF2-beta;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4;	 PF07533;PF00439;PF00271;PF07529;PF08880;PF14619;PF00176;	 GO:0000785;GO:0005615;GO:0016020;GO:0071565;GO:0071564;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0050681;GO:0005524;GO:0008094;GO:0003677;GO:0070182;GO:0004386;GO:0070577;GO:0070615;GO:0002039;GO:0047485;GO:0003723;GO:0030957;GO:0003713;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0006325;GO:0006338;GO:0038111;GO:0060766;GO:0030308;GO:0000122;GO:0045892;GO:0007399;GO:0003407;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:1902895;GO:0045944;GO:1901838;GO:0045893;GO:0030177;GO:0006357;GO:0001188;	  C:chromatin; C:extracellular space; C:membrane; C:nBAF complex; C:npBAF complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;	  F:androgen receptor binding; F:ATP binding; F:ATPase activity, acting on DNA; F:DNA binding; F:DNA polymerase binding; F:helicase activity; F:lysine-acetylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding; F:protein N-terminus binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;	  P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:chromatin organization; P:chromatin remodeling; P:interleukin-7-mediated signaling pathway; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neural retina development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly;
XM_040186993.1	chrIX	996420	996420	chrIX	989250	991503	-	XM_040186993.1	path1	A0A087WSX0	Immunoglobulin lambda variable 5-45 {ECO:0000303|PubMed:11872955, ECO:0000303|Ref.3}		 PF07686;	 GO:0005615;GO:0019814;GO:0005886;GO:0002250;GO:0006955;	  C:extracellular space; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response; P:immune response;
XM_040187286.1	chrIX	1459563	1459563	chrIX	1440076	1450417	+	XM_040187286.1	path1	Q641Z2 Q8K3Y9	Tyrosine-protein phosphatase non-receptor type 9		 PF00650;PF00102;	 GO:0005737;GO:0044306;GO:0004725;GO:0010977;GO:0035335;GO:1903078;GO:0006470;	  C:cytoplasm; C:neuron projection terminus;	  F:protein tyrosine phosphatase activity;	  P:negative regulation of neuron projection development; P:peptidyl-tyrosine dephosphorylation; P:positive regulation of protein localization to plasma membrane; P:protein dephosphorylation;
XR_005713135.1	chrIX	1459563	1459563	chrIX	1449303	1454408	-	XR_005713135.1	path1	Q3UTY6 Q8BLE5	Thrombospondin type-1 domain-containing protein 4	A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6;ADAMTS-like protein 4;	 PF05986;PF08686;PF00090;	 GO:0031012;GO:0005576;GO:0001527;GO:0004222;GO:0048251;GO:0030198;	  C:extracellular matrix; C:extracellular region; C:microfibril;	  F:metalloendopeptidase activity;	  P:elastic fiber assembly; P:extracellular matrix organization;
XR_005713136.1	chrIX	1459563	1459563	chrIX	1454449	1455909	-	XR_005713136.1	path1	Q6ZMP0 B2RTY3 B4DR13 Q6MZI3 Q6UXZ8 Q9H8E4	Thrombospondin type-1 domain-containing protein 4	A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6;	 PF05986;PF08686;PF00090;	 GO:0062023;GO:0070062;GO:0031012;GO:0001527;GO:0004222;GO:0048251;GO:0030198;	  C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular matrix; C:microfibril;	  F:metalloendopeptidase activity;	  P:elastic fiber assembly; P:extracellular matrix organization;
XM_040187292.1	chrIX	1459563	1459563	chrIX	1458864	1465303	+	XM_040187292.1	path1	F1QGZ6 Q7ZU72 Q7ZZN5	Maternal embryonic leucine zipper kinase	Protein kinase PK38;	 PF02149;PF00069;	 GO:0005938;GO:0005737;GO:0005634;GO:0005886;GO:0005524;GO:0005509;GO:0008289;GO:0004715;GO:0106310;GO:0004674;GO:0106311;GO:0006915;GO:0007049;GO:0008283;GO:0048821;GO:0030097;GO:0035556;GO:0061351;GO:0043065;GO:0046777;GO:0006468;GO:0008016;	  C:cell cortex; C:cytoplasm; C:nucleus; C:plasma membrane;	  F:ATP binding; F:calcium ion binding; F:lipid binding; F:non-membrane spanning protein tyrosine kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:apoptotic process; P:cell cycle; P:cell population proliferation; P:erythrocyte development; P:hemopoiesis; P:intracellular signal transduction; P:neural precursor cell proliferation; P:positive regulation of apoptotic process; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of heart contraction;
XM_040187344.1	chrIX	1461270	1461270	chrIX	1479282	1517477	-	XM_040187344.1	path1	Q9YH95	Paired box protein Pax-5		 PF00292;PF12403;	 GO:0005634;GO:0003677;GO:0003700;GO:0007275;GO:0006355;	  C:nucleus;	  F:DNA binding; F:DNA-binding transcription factor activity;	  P:multicellular organism development; P:regulation of transcription, DNA-templated;
XM_040187270.1	chrIX	1627357	1627357	chrIX	1570270	1606569	+	XM_040187270.1	path1	Q60949 E9QLW9 Q80TJ9 Q923F8	TBC1 domain family member 1		 PF11830;PF00640;PF00566;	 GO:0005829;GO:0005634;GO:0005096;GO:0090630;GO:0006886;GO:0032880;	  C:cytosol; C:nucleus;	  F:GTPase activator activity;	  P:activation of GTPase activity; P:intracellular protein transport; P:regulation of protein localization;
XM_040187322.1	chrIX	1627357	1627357	chrIX	1619593	1630573	+	XM_040187322.1	path1	P57682 Q6PIR1 Q86TN0 Q9P2X6	Krueppel-like factor 3	Basic krueppel-like factor;CACCC-box-binding protein BKLF;TEF-2;	 PF00096;	 GO:0000785;GO:0005654;GO:0003700;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:1901653;GO:0007275;GO:0000122;GO:0006357;	  C:chromatin; C:nucleoplasm;	  F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:cellular response to peptide; P:multicellular organism development; P:negative regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;
XM_040175855.1	chrV	5684473	5684473	chrV	5675251	5706933	-	XM_040175855.1	path1	Q9QXY2 Q9QXY3	SRC kinase signaling inhibitor 1 {ECO:0000305}	SNAP-25-interacting protein;p130Cas-associated protein;p140Cap {ECO:0000303|PubMed:18662323};	 PF03915;	 GO:0015629;GO:0030424;GO:0005737;GO:0030425;GO:0030175;GO:0030027;GO:0043005;GO:0043025;GO:0014069;GO:0098793;GO:0045202;GO:0030234;GO:0019904;GO:0019901;GO:0006887;GO:0007162;GO:0050709;GO:0061099;GO:0061098;GO:0030334;GO:0061001;GO:0034446;	  C:actin cytoskeleton; C:axon; C:cytoplasm; C:dendrite; C:filopodium; C:lamellipodium; C:neuron projection; C:neuronal cell body; C:postsynaptic density; C:presynapse; C:synapse;	  F:enzyme regulator activity; F:protein domain specific binding; F:protein kinase binding;	  P:exocytosis; P:negative regulation of cell adhesion; P:negative regulation of protein secretion; P:negative regulation of protein tyrosine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:substrate adhesion-dependent cell spreading;
XM_040177901.1	chrVI	8469593	8469593	chrVI	8471721	8476180	+	XM_040177901.1	path1	Q8VEH8 Q3UZF3 Q8BVN6	Endoplasmic reticulum lectin 1	ER lectin;	 PF07915;	 GO:0005788;GO:0051082;GO:1904153;GO:0030433;	  C:endoplasmic reticulum lumen;	  F:unfolded protein binding;	  P:negative regulation of retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway;
XM_040178142.1	chrVI	8573377	8573377	chrVI	8570225	8574990	+	XM_040178142.1	path1	Q5E9R2 Q5EA78	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	1-acylglycerol-3-phosphate O-acyltransferase 4;Lysophosphatidic acid acyltransferase delta;	 PF16076;PF01553;	 GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0005741;GO:0003841;GO:0016746;GO:0016024;	  C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane;	  F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;	  P:CDP-diacylglycerol biosynthetic process;
XM_040178137.1	chrVI	8573377	8573377	chrVI	8576382	8593045	-	XM_040178137.1	path1	Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408	Mitogen-activated protein kinase kinase kinase 4	MAP three kinase 1;MAPK/ERK kinase kinase 4;	 PF00069;	 GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;	  C:cytoplasm; C:perinuclear region of cytoplasm;	  F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;	  P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;
XM_040178626.1	chrVI	16228670	16228670	chrVI	16183136	16400991	-	XM_040178626.1	path1	O35181	Pro-neuregulin-3, membrane-bound isoform		 	 GO:0005615;GO:0098978;GO:0016021;GO:0005886;GO:0045499;GO:0008083;GO:0005102;GO:0048513;GO:0021842;GO:0035556;GO:0030879;GO:0060596;GO:0050804;GO:2001223;GO:0007389;	  C:extracellular space; C:glutamatergic synapse; C:integral component of membrane; C:plasma membrane;	  F:chemorepellent activity; F:growth factor activity; F:signaling receptor binding;	  P:animal organ development; P:chemorepulsion involved in interneuron migration from the subpallium to the cortex; P:intracellular signal transduction; P:mammary gland development; P:mammary placode formation; P:modulation of chemical synaptic transmission; P:negative regulation of neuron migration; P:pattern specification process;
XM_040179224.1	chrVI	16462504	16462504	chrVI	16472723	16474317	+	XM_040179224.1	path1	O93209	Pro-Pol polyprotein	Pr125Pol;	 PF17921;PF00075;PF00665;PF00078;PF18103;PF03539;	 GO:0030430;GO:0042025;GO:0019012;GO:0004190;GO:0003887;GO:0046872;GO:0003723;GO:0003964;GO:0004523;GO:0015074;GO:0006310;GO:0075713;GO:0046718;GO:0044826;GO:0075732;	  C:host cell cytoplasm; C:host cell nucleus; C:virion;	  F:aspartic-type endopeptidase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity;	  P:DNA integration; P:DNA recombination; P:establishment of integrated proviral latency; P:viral entry into host cell; P:viral genome integration into host DNA; P:viral penetration into host nucleus;
XM_040178868.1	chrVI	16553484	16553484	chrVI	16565798	16621541	+	XM_040178868.1	path1	O13156	GDNF family receptor alpha-1	TGF-beta-related neurotrophic factor receptor 1;	 PF02351;	 GO:0031225;GO:0009897;GO:0043235;GO:0038023;GO:0007399;	  C:anchored component of membrane; C:external side of plasma membrane; C:receptor complex;	  F:signaling receptor activity;	  P:nervous system development;
XM_040168904.1	chrVI	16578969	16578969	chrVI	16573653	16622284	+	XM_040168904.1	path1	P56945 B3KWD7 B4DEV4 B4DGB5 B4DIW5 B7Z7X7 E9PCL5 E9PCV2 F5GXA2 F5GXV6 F5H7Z0 F8WA69 Q6QEF7	Breast cancer anti-estrogen resistance protein 1	CRK-associated substrate;Cas scaffolding protein family member 1;p130cas;	 PF12026;PF08824;PF00018;	 GO:0015629;GO:0030424;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0001726;GO:0019901;GO:0017124;GO:0007015;GO:0090527;GO:0050851;GO:0050853;GO:0007155;GO:0060326;GO:0051301;GO:0016477;GO:0035729;GO:0086100;GO:0007173;GO:0007186;GO:0048012;GO:0008286;GO:0007229;GO:0048011;GO:0048008;GO:0030335;GO:0010595;GO:0042981;GO:0001558;GO:0050852;GO:0007169;GO:0048010;	  C:actin cytoskeleton; C:axon; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:ruffle;	  F:protein kinase binding; F:SH3 domain binding;	  P:actin filament organization; P:actin filament reorganization; P:antigen receptor-mediated signaling pathway; P:B cell receptor signaling pathway; P:cell adhesion; P:cell chemotaxis; P:cell division; P:cell migration; P:cellular response to hepatocyte growth factor stimulus; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hepatocyte growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell migration; P:positive regulation of endothelial cell migration; P:regulation of apoptotic process; P:regulation of cell growth; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;
XM_040179009.1	chrVI	16612657	16612657	chrVI	16623993	16746976	-	XM_040179009.1	path1	Q6A051 Q3UHB0 Q68HV2 Q80VI3 Q8BKS4 Q8K0P5	Attractin-like protein 1		 PF00431;PF07974;PF00053;PF00059;PF01437;	 GO:0005604;GO:0016021;GO:0005886;GO:0030246;GO:0009887;GO:0016477;GO:0007186;GO:0034446;GO:0009888;	  C:basement membrane; C:integral component of membrane; C:plasma membrane;	  F:carbohydrate binding;	  P:animal organ morphogenesis; P:cell migration; P:G protein-coupled receptor signaling pathway; P:substrate adhesion-dependent cell spreading; P:tissue development;
XM_040185242.1	chrVIII	11390203	11390203	chrVIII	11317270	11506768	+	XM_040185242.1	path1	Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7	Receptor-type tyrosine-protein phosphatase S	Receptor-type tyrosine-protein phosphatase sigma;	 PF00041;PF07679;PF00102;	 GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;	  C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;	  F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;	  P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;
XM_040184116.1	chrVIII	11537054	11537054	chrVIII	11517332	11526797	+	XM_040184116.1	path1	Q95125 Q95124	Thromboxane A2 receptor	Prostanoid TP receptor;	 PF00001;	 GO:0016021;GO:0016607;GO:0005886;GO:0004961;GO:0007189;GO:0006954;GO:0090051;GO:0045777;GO:0007204;GO:0045987;GO:0045907;GO:0032496;GO:0019932;	  C:integral component of membrane; C:nuclear speck; C:plasma membrane;	  F:thromboxane A2 receptor activity;	  P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of blood pressure; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of smooth muscle contraction; P:positive regulation of vasoconstriction; P:response to lipopolysaccharide; P:second-messenger-mediated signaling;
XM_040184947.1	chrVIII	11657660	11657660	chrVIII	11625003	11693173	+	XM_040184947.1	path1	Q7Z7M1 Q86SL4 Q8NH12	Adhesion G-protein coupled receptor D2 {ECO:0000303|PubMed:25713288}	G-protein coupled receptor 144;G-protein coupled receptor PGR24;	 PF00002;PF01825;PF00354;	 GO:0016021;GO:0005887;GO:0004930;GO:0007189;GO:0007166;GO:0007186;	  C:integral component of membrane; C:integral component of plasma membrane;	  F:G protein-coupled receptor activity;	  P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway;
XM_040184878.1	chrVIII	12565925	12565925	chrVIII	12557225	12564156	+	XM_040184878.1	path1	Q9EPC6 Q9JHU7	Profilin-2	Profilin II;	 PF00235;	 GO:0005737;GO:0005856;GO:0098978;GO:0098794;GO:0098793;GO:0098685;GO:0043195;GO:0003779;GO:0003785;GO:0016887;GO:0005546;GO:0030036;GO:0098885;GO:0030837;GO:0010633;GO:1900028;GO:0032233;GO:0030838;GO:0032781;GO:0033138;GO:0051496;GO:0050821;GO:0030833;GO:2000300;	  C:cytoplasm; C:cytoskeleton; C:glutamatergic synapse; C:postsynapse; C:presynapse; C:Schaffer collateral - CA1 synapse; C:terminal bouton;	  F:actin binding; F:actin monomer binding; F:ATPase activity; F:phosphatidylinositol-4,5-bisphosphate binding;	  P:actin cytoskeleton organization; P:modification of postsynaptic actin cytoskeleton; P:negative regulation of actin filament polymerization; P:negative regulation of epithelial cell migration; P:negative regulation of ruffle assembly; P:positive regulation of actin filament bundle assembly; P:positive regulation of actin filament polymerization; P:positive regulation of ATPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of stress fiber assembly; P:protein stabilization; P:regulation of actin filament polymerization; P:regulation of synaptic vesicle exocytosis;
XM_040184875.1	chrVIII	12565925	12565925	chrVIII	12564024	12571960	-	XM_040184875.1	path1	Q90972 Q533M4	E3 ubiquitin-protein ligase RNF13	C-RZF;RING finger protein 13;RING-type E3 ubiquitin transferase RNF13 {ECO:0000305};	 PF02225;PF13639;	 GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0031902;GO:0005765;GO:0005654;GO:0008432;GO:0046872;GO:0061630;GO:0004842;GO:0070304;GO:0051865;GO:0006511;	  C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:nucleoplasm;	  F:JUN kinase binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;	  P:positive regulation of stress-activated protein kinase signaling cascade; P:protein autoubiquitination; P:ubiquitin-dependent protein catabolic process;
XM_040185057.1	chrVIII	12720737	12720737	chrVIII	12726376	12728139	-	XM_040185057.1	path1	Q8AVU4	Transcription factor HES-1-B	Hairy and enhancer of split 1-B;	 PF07527;PF00010;	 GO:0005634;GO:0043425;GO:0003677;GO:0046982;GO:0007275;GO:0048635;GO:0000122;GO:0045892;GO:0007219;	  C:nucleus;	  F:bHLH transcription factor binding; F:DNA binding; F:protein heterodimerization activity;	  P:multicellular organism development; P:negative regulation of muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway;
XM_040184261.1	chrVIII	13129255	13129255	chrVIII	13094564	13207665	-	XM_040184261.1	path1	Q7Z3B1 Q5VT21 Q6UY06 Q8N440 Q8NAQ3	Neuronal growth regulator 1	IgLON family member 4;	 PF07679;	 GO:0031225;GO:0005576;GO:0005886;GO:0098609;GO:0007631;GO:0007626;GO:0010976;	  C:anchored component of membrane; C:extracellular region; C:plasma membrane;	 	  P:cell-cell adhesion; P:feeding behavior; P:locomotory behavior; P:positive regulation of neuron projection development;
XM_040187855.1	chrX	16305683	16305683	chrX	16305113	16314034	-	XM_040187855.1	path1	P62760 D6W515 P28677 P29103 P42323 Q9UM20	Visinin-like protein 1	Hippocalcin-like protein 3;	 PF00036;PF13499;	 GO:0005829;GO:0016020;GO:0005509;GO:0046676;GO:0045921;GO:0035774;	  C:cytosol; C:membrane;	  F:calcium ion binding;	  P:negative regulation of insulin secretion; P:positive regulation of exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;
XM_040190861.1	chrXI	13937700	13937700	chrXI	13917074	13938176	-	XM_040190861.1	path1	P24507	Synaptotagmin-C	Synaptic vesicle protein O-p65-C;	 PF00168;	 GO:0016021;GO:0030672;GO:0046872;GO:0017156;	  C:integral component of membrane; C:synaptic vesicle membrane;	  F:metal ion binding;	  P:calcium-ion regulated exocytosis;
XM_040190912.1	chrXI	13971773	13971773	chrXI	13960931	14010458	-	XM_040190912.1	path1	D3YZU1	SH3 and multiple ankyrin repeat domains protein 1		 PF12796;PF17820;PF00536;PF07653;	 GO:0005737;GO:0030425;GO:0043197;GO:0060076;GO:0098978;GO:0016020;GO:0043005;GO:0017146;GO:0005886;GO:0014069;GO:0045211;GO:0098685;GO:0045202;GO:0071532;GO:0042802;GO:0035255;GO:0008022;GO:0044877;GO:0097110;GO:0017124;GO:0030159;GO:0031877;GO:0098919;GO:0030160;GO:0030534;GO:0008306;GO:0048854;GO:0060997;GO:0050894;GO:0046959;GO:0007616;GO:0060291;GO:0032232;GO:0050885;GO:0042048;GO:0060999;GO:2000463;GO:0051968;GO:0099173;GO:0097107;GO:0035418;GO:0065003;GO:2000311;GO:0060013;GO:0035176;GO:0060074;GO:0051124;GO:0071625;	  C:cytoplasm; C:dendrite; C:dendritic spine; C:excitatory synapse; C:glutamatergic synapse; C:membrane; C:neuron projection; C:NMDA selective glutamate receptor complex; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:Schaffer collateral - CA1 synapse; C:synapse;	  F:ankyrin repeat binding; F:identical protein binding; F:ionotropic glutamate receptor binding; F:protein C-terminus binding; F:protein-containing complex binding; F:scaffold protein binding; F:SH3 domain binding; F:signaling receptor complex adaptor activity; F:somatostatin receptor binding; F:structural constituent of postsynaptic density; F:synaptic receptor adaptor activity;	  P:adult behavior; P:associative learning; P:brain morphogenesis; P:dendritic spine morphogenesis; P:determination of affect; P:habituation; P:long-term memory; P:long-term synaptic potentiation; P:negative regulation of actin filament bundle assembly; P:neuromuscular process controlling balance; P:olfactory behavior; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of synaptic transmission, glutamatergic; P:postsynapse organization; P:postsynaptic density assembly; P:protein localization to synapse; P:protein-containing complex assembly; P:regulation of AMPA receptor activity; P:righting reflex; P:social behavior; P:synapse maturation; P:synaptic growth at neuromuscular junction; P:vocalization behavior;
XM_040190548.1	chrXI	14089717	14089717	chrXI	14087736	14091600	-	XM_040190548.1	path1	P62869 Q63529 Q80W20	Elongin-B	Elongin 18 kDa subunit;RNA polymerase II transcription factor SIII subunit B;SIII p18;Transcription elongation factor B polypeptide 2;	 PF00240;	 GO:0070449;GO:0005667;GO:0030891;GO:0044877;GO:0003713;GO:0045944;GO:0016567;GO:0006368;	  C:elongin complex; C:transcription regulator complex; C:VCB complex;	  F:protein-containing complex binding; F:transcription coactivator activity;	  P:positive regulation of transcription by RNA polymerase II; P:protein ubiquitination; P:transcription elongation from RNA polymerase II promoter;
XM_040190515.1	chrXI	14089717	14089717	chrXI	14092980	14097303	-	XM_040190515.1	path1	A4FUB7	Gypsy retrotransposon integrase-like protein 1		 PF17921;	 GO:0003676;GO:0015074;	 	  F:nucleic acid binding;	  P:DNA integration;
XM_040190913.1	chrXI	14180102	14180102	chrXI	14174492	14180722	+	XM_040190913.1	path1	Q91YU8 Q8BYM4	Suppressor of SWI4 1 homolog	Peter Pan homolog;	 PF04427;	 GO:0005730;GO:0005634;GO:0030687;GO:0019843;GO:0001560;GO:0000027;GO:0006364;	  C:nucleolus; C:nucleus; C:preribosome, large subunit precursor;	  F:rRNA binding;	  P:regulation of cell growth by extracellular stimulus; P:ribosomal large subunit assembly; P:rRNA processing;
XM_040191861.1	chrXI	14180102	14180102	chrXI	14183605	14186093	+	XM_040191861.1	path1	Q6DRC4 A8E573 Q7ZUH3	Eukaryotic translation initiation factor 3 subunit G {ECO:0000255|HAMAP-Rule:MF_03006}	Eukaryotic translation initiation factor 3 RNA-binding subunit {ECO:0000255|HAMAP-Rule:MF_03006};Eukaryotic translation initiation factor 3 subunit 4 {ECO:0000255|HAMAP-Rule:MF_03006};	 PF12353;PF00076;	 GO:0016282;GO:0033290;GO:0005852;GO:0003743;GO:0001732;GO:0006413;	  C:eukaryotic 43S preinitiation complex; C:eukaryotic 48S preinitiation complex; C:eukaryotic translation initiation factor 3 complex;	  F:translation initiation factor activity;	  P:formation of cytoplasmic translation initiation complex; P:translational initiation;
XM_040192929.1	chrXII	10132797	10132797	chrXII	10121813	10136267	+	XM_040192929.1	path1	O88721	Vasopressin V2 receptor	AVPR V2;Antidiuretic hormone receptor;Renal-type arginine vasopressin receptor;	 PF00001;	 GO:0030139;GO:0005768;GO:0005887;GO:0048471;GO:0005886;GO:0004930;GO:0042277;GO:0005000;GO:0007186;GO:0007249;GO:0008285;GO:0035814;GO:0035811;GO:0045777;GO:0008284;GO:0010628;GO:0003084;GO:0045907;GO:0001992;GO:0034097;GO:0021537;	  C:endocytic vesicle; C:endosome; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;	  F:G protein-coupled receptor activity; F:peptide binding; F:vasopressin receptor activity;	  P:G protein-coupled receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of cell population proliferation; P:negative regulation of renal sodium excretion; P:negative regulation of urine volume; P:positive regulation of blood pressure; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of systemic arterial blood pressure; P:positive regulation of vasoconstriction; P:regulation of systemic arterial blood pressure by vasopressin; P:response to cytokine; P:telencephalon development;
XM_040192896.1	chrXII	10190117	10190117	chrXII	10171456	10198018	-	XM_040192896.1	path1	O43306 Q9NR75 Q9UDB0	Adenylate cyclase type 6	ATP pyrophosphate-lyase 6;Adenylate cyclase type VI;Adenylyl cyclase 6 {ECO:0000303|PubMed:17916776};Ca(2+)-inhibitable adenylyl cyclase;	 PF16214;PF06327;PF00211;	 GO:0005929;GO:0005887;GO:0031226;GO:0016020;GO:0005886;GO:0032420;GO:0004016;GO:0005524;GO:0046872;GO:0019901;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0097746;GO:0006171;GO:0071870;GO:1904322;GO:0071377;GO:0071380;GO:1904117;GO:0007212;GO:0007186;GO:0035556;GO:0002862;GO:0010977;GO:0035811;GO:0003091;	  C:cilium; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane; C:stereocilium;	  F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein kinase C binding;	  P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:blood vessel diameter maintenance; P:cAMP biosynthetic process; P:cellular response to catecholamine stimulus; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to vasopressin; P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron projection development; P:negative regulation of urine volume; P:renal water homeostasis;
XM_040193477.1	chrXII	10445225	10445225	chrXII	10435913	10444630	-	XM_040193477.1	path1	Q867C9	ATP-dependent 6-phosphofructokinase, muscle type {ECO:0000255|HAMAP-Rule:MF_03184}	6-phosphofructokinase type A;Phosphofructo-1-kinase isozyme A;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};	 PF00365;	 GO:0005945;GO:0016020;GO:0003872;GO:0016208;GO:0005524;GO:0070095;GO:0042802;GO:0046872;GO:0048029;GO:0061621;GO:0030388;GO:0006002;	  C:6-phosphofructokinase complex; C:membrane;	  F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose-6-phosphate binding; F:identical protein binding; F:metal ion binding; F:monosaccharide binding;	  P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process;
XM_040193244.1	chrXII	10477833	10477833	chrXII	10470042	10473642	+	XM_040193244.1	path1	Q9UHC7 A4D1T7 B3KXB4 Q256Y7 Q59G11 Q6GSF1 Q9H0G0 Q9UEZ7 Q9UHW2	E3 ubiquitin-protein ligase makorin-1	RING finger protein 61;RING-type E3 ubiquitin transferase makorin-1 {ECO:0000305};	 PF15815;PF00097;PF00642;PF18044;	 GO:0005829;GO:0046872;GO:0003723;GO:0061630;GO:0000209;GO:0016567;	  C:cytosol;	  F:metal ion binding; F:RNA binding; F:ubiquitin protein ligase activity;	  P:protein polyubiquitination; P:protein ubiquitination;
XM_040193247.1	chrXII	10477833	10477833	chrXII	10470042	10473642	+	XM_040193247.1	path1	Q5NU14 Q5KSL0	Probable E3 ubiquitin-protein ligase makorin-1	RING-type E3 ubiquitin transferase makorin-1 {ECO:0000305};	 PF15815;PF00097;PF18044;	 GO:0046872;GO:0016740;GO:0016567;	 	  F:metal ion binding; F:transferase activity;	  P:protein ubiquitination;
XM_040193243.1	chrXII	10477833	10477833	chrXII	10470055	10473642	+	XM_040193243.1	path1	Q13434	Putative E3 ubiquitin-protein ligase makorin-4	Makorin RING finger protein pseudogene 4;Makorin RING finger protein pseudogene 5;RING finger protein 64;RING-type E3 ubiquitin transferase makorin-4 {ECO:0000305};Zinc finger protein 127-Xp;Zinc finger protein 127-like 1;	 PF15815;PF00097;PF18044;	 GO:0046872;GO:0061630;GO:0016567;	 	  F:metal ion binding; F:ubiquitin protein ligase activity;	  P:protein ubiquitination;
XM_040193619.1	chrXII	10477833	10477833	chrXII	10473803	10477603	+	XM_040193619.1	path1	Q9HB96 A8K907 Q4ZGH2	Fanconi anemia group E protein		 PF11510;	 GO:0043240;GO:0005654;GO:0005634;GO:0036297;	  C:Fanconi anaemia nuclear complex; C:nucleoplasm; C:nucleus;	 	  P:interstrand cross-link repair;
XM_040193625.1	chrXII	10477833	10477833	chrXII	10477962	10480203	+	XM_040193625.1	path1	Q90YV8	60S ribosomal protein L10a		 PF00687;	 GO:0015934;GO:0003723;GO:0003735;GO:0042541;GO:0006412;	  C:large ribosomal subunit;	  F:RNA binding; F:structural constituent of ribosome;	  P:hemoglobin biosynthetic process; P:translation;
XM_040193622.1	chrXII	10477833	10477833	chrXII	10480340	10484509	+	XM_040193622.1	path1	Q12912 A0AVM2 B4E077 Q8N301	Inositol 1,4,5-triphosphate receptor associated 2 {ECO:0000305}	Lymphoid-restricted membrane protein;Protein Jaw1;	 PF05781;	 GO:0035577;GO:0005694;GO:0005789;GO:0016021;GO:0005887;GO:0016020;GO:0005815;GO:0005635;GO:0005886;GO:0000922;GO:0008017;GO:0043312;GO:0006997;GO:0007338;GO:0006906;GO:0006903;	  C:azurophil granule membrane; C:chromosome; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:microtubule organizing center; C:nuclear envelope; C:plasma membrane; C:spindle pole;	  F:microtubule binding;	  P:neutrophil degranulation; P:nucleus organization; P:single fertilization; P:vesicle fusion; P:vesicle targeting;
XM_040193621.1	chrXII	10477833	10477833	chrXII	10483597	10491222	-	XM_040193621.1	path1	Q3KP66 B4E1K9 E9PFY0 Q9NV65 Q9NVI0	Innate immunity activator protein {ECO:0000312|HGNC:HGNC:25599}		 PF11819;	 GO:0005737;GO:0005634;GO:0000187;GO:0034334;GO:0045087;GO:0060729;GO:0070431;GO:0002221;GO:0002720;GO:0043123;GO:0032731;GO:0032733;GO:0032755;GO:0031398;GO:0032874;GO:1903409;GO:0032495;GO:0032494;	  C:cytoplasm; C:nucleus;	 	  P:activation of MAPK activity; P:adherens junction maintenance; P:innate immune response; P:intestinal epithelial structure maintenance; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:pattern recognition receptor signaling pathway; P:positive regulation of cytokine production involved in immune response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-6 production; P:positive regulation of protein ubiquitination; P:positive regulation of stress-activated MAPK cascade; P:reactive oxygen species biosynthetic process; P:response to muramyl dipeptide; P:response to peptidoglycan;
XM_040193427.1	chrXII	16140847	16140847	chrXII	16035260	16190309	-	XM_040193427.1	path1	Q9UIW2	Plexin-A1	Semaphorin receptor NOV;	 PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;	 GO:0005829;GO:0070062;GO:0005887;GO:0005654;GO:0005886;GO:0002116;GO:0017154;GO:0038023;GO:0060666;GO:0007275;GO:0007162;GO:1990138;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:0014910;GO:1902287;	  C:cytosol; C:extracellular exosome; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:semaphorin receptor complex;	  F:semaphorin receptor activity; F:signaling receptor activity;	  P:dichotomous subdivision of terminal units involved in salivary gland branching; P:multicellular organism development; P:negative regulation of cell adhesion; P:neuron projection extension; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of smooth muscle cell migration; P:semaphorin-plexin signaling pathway involved in axon guidance;
XM_040193507.1	chrXII	16252958	16252958	chrXII	16251146	16300342	-	XM_040193507.1	path1	Q63ZW2	MICOS complex subunit mic25a	Coiled-coil-helix-coiled-coil-helix domain-containing protein 6;	 	 GO:0061617;GO:0005743;GO:0005739;GO:0006974;GO:0042407;GO:0007007;	  C:MICOS complex; C:mitochondrial inner membrane; C:mitochondrion;	 	  P:cellular response to DNA damage stimulus; P:cristae formation; P:inner mitochondrial membrane organization;
XM_040196053.1	chrXIII	2944819	2944819	chrXIII	2944369	2955873	-	XM_040196053.1	path1	Q9H9H4	Vacuolar protein sorting-associated protein 37B	ESCRT-I complex subunit VPS37B;	 PF07200;	 GO:0005737;GO:0005768;GO:0010008;GO:0000813;GO:0070062;GO:0043657;GO:0043231;GO:0031902;GO:0030496;GO:0005886;GO:0048306;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:1903774;GO:1902188;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;	  C:cytoplasm; C:endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:midbody; C:plasma membrane;	  F:calcium-dependent protein binding;	  P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral release from host cell; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle;
XM_040195741.1	chrXIII	11085100	11085100	chrXIII	10977247	11103396	-	XM_040195741.1	path1	Q7T297	Cotranscriptional regulator FAM172A homolog {ECO:0000250|UniProtKB:Q3TNH5}	Protein FAM172A;	 	 GO:0005737;GO:0005634;GO:0031048;GO:0006397;GO:0000381;GO:0008380;	  C:cytoplasm; C:nucleus;	 	  P:heterochromatin assembly by small RNA; P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;
XM_040196160.1	chrXIII	16653560	16653560	chrXIII	16646042	16671775	-	XM_040196160.1	path1	Q5DUB1	Substance-P receptor	NK-1 receptor;Tachykinin receptor 1;	 PF00001;	 GO:0016021;GO:0005886;GO:0061827;GO:0097225;GO:0016496;GO:0007204;GO:1902093;GO:0070472;GO:0048265;	  C:integral component of membrane; C:plasma membrane; C:sperm head; C:sperm midpiece;	  F:substance P receptor activity;	  P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of flagellated sperm motility; P:regulation of uterine smooth muscle contraction; P:response to pain;
XM_040196247.1	chrXIII	16693494	16693494	chrXIII	16675903	16684578	+	XM_040196247.1	path1	O95858 Q6UW79	Tetraspanin-15	Tetraspan NET-7;Transmembrane 4 superfamily member 15;	 PF00335;	 GO:0030054;GO:0009986;GO:0005829;GO:0005788;GO:0005887;GO:0043231;GO:0031902;GO:0016604;GO:0005886;GO:0097197;GO:0019899;GO:1990000;GO:0045746;GO:0072659;GO:0051604;	  C:cell junction; C:cell surface; C:cytosol; C:endoplasmic reticulum lumen; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:nuclear body; C:plasma membrane; C:tetraspanin-enriched microdomain;	  F:enzyme binding;	  P:amyloid fibril formation; P:negative regulation of Notch signaling pathway; P:protein localization to plasma membrane; P:protein maturation;
XM_040194697.1	chrXIII	16693494	16693494	chrXIII	16688618	16710676	+	XM_040194697.1	path1	Q6RI88	Electrogenic sodium bicarbonate cotransporter 4	Solute carrier family 4 member 5;	 PF07565;PF00955;	 GO:0016324;GO:0016323;GO:0016021;GO:0005886;GO:0015301;GO:0005452;GO:0008510;GO:0022857;GO:0006820;GO:0015701;GO:0033326;GO:0002064;GO:0050801;GO:0006811;GO:0048311;GO:0010468;GO:0051453;GO:0006885;GO:0003073;GO:0003014;GO:0060041;GO:0055085;	  C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane;	  F:anion:anion antiporter activity; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;	  P:anion transport; P:bicarbonate transport; P:cerebrospinal fluid secretion; P:epithelial cell development; P:ion homeostasis; P:ion transport; P:mitochondrion distribution; P:regulation of gene expression; P:regulation of intracellular pH; P:regulation of pH; P:regulation of systemic arterial blood pressure; P:renal system process; P:retina development in camera-type eye; P:transmembrane transport;
XM_040194695.1	chrXIII	16891928	16891928	chrXIII	16832388	16881995	-	XM_040194695.1	path1	O14976 Q5U4P5 Q9BVY6	Cyclin-G-associated kinase		 PF00069;PF10409;	 GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;	  C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;	  F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating;
XM_040195986.1	chrXIII	16891928	16891928	chrXIII	16884885	16910275	+	XM_040195986.1	path1	A3QK15 Q7ZU87	Acetoacetyl-CoA synthetase		 PF16177;PF00501;	 GO:0005829;GO:0030729;GO:0005524;GO:0006631;GO:0032024;	  C:cytosol;	  F:acetoacetate-CoA ligase activity; F:ATP binding;	  P:fatty acid metabolic process; P:positive regulation of insulin secretion;
XM_040195985.1	chrXIII	16947343	16947343	chrXIII	16932602	17079402	+	XM_040195985.1	path1	Q8CEF9 Q8BS69	Transmembrane protein 132C		 PF16070;PF15706;PF15705;	 GO:0016021;GO:0010923;	  C:integral component of membrane;	 	  P:negative regulation of phosphatase activity;
XM_040196267.1	chrXIII	17457812	17457812	chrXIII	17437873	17440325	-	XM_040196267.1	path1	Q16559 A0AVI7	T-cell acute lymphocytic leukemia protein 2	Class A basic helix-loop-helix protein 19;	 PF00010;	 GO:0000785;GO:0003677;GO:0000981;GO:0046983;GO:0000978;GO:0030901;GO:0035264;GO:0009791;GO:0006357;GO:0021794;	  C:chromatin;	  F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:midbrain development; P:multicellular organism growth; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:thalamus development;
XR_005714011.1	chrXIII	17457812	17457812	chrXIII	17440620	17446255	+	XR_005714011.1	path1	Q5VXU9 A2A2V3 Q2M1H8 Q96M73	Protein shortage in chiasmata 1 ortholog {ECO:0000305}	Protein ZIP2 homolog {ECO:0000250|UniProtKB:A2ALV5};	 PF17825;	 GO:0005694;GO:0000794;GO:0016887;GO:0003697;GO:0007131;GO:0000712;	  C:chromosome; C:condensed nuclear chromosome;	  F:ATPase activity; F:single-stranded DNA binding;	  P:reciprocal meiotic recombination; P:resolution of meiotic recombination intermediates;
XM_040196671.1	chrXIII	17457812	17457812	chrXIII	17453233	17461950	-	XM_040196671.1	path1	Q7RTR2 Q5EY36 Q8NF48 Q8NI01 Q8NI02 Q8TEL3	NLR family CARD domain-containing protein 3	CARD15-like protein;Caterpiller protein 16.2 {ECO:0000303|PubMed:15705585};NACHT, LRR and CARD domains-containing protein 3;Nucleotide-binding oligomerization domain protein 3;	 PF13516;PF05729;PF17776;PF17779;	 GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0048471;GO:0005524;GO:0036312;GO:0007249;GO:0035556;GO:1900016;GO:0050680;GO:0048147;GO:0043124;GO:0050728;GO:0045824;GO:0032687;GO:0032688;GO:0032715;GO:0032088;GO:1901223;GO:1900226;GO:0014067;GO:0032720;GO:0042110;	  C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm;	  F:ATP binding; F:phosphatidylinositol 3-kinase regulatory subunit binding;	  P:I-kappaB kinase/NF-kappaB signaling; P:intracellular signal transduction; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of epithelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of tumor necrosis factor production; P:T cell activation;
XM_040196622.1	chrXIII	17457812	17457812	chrXIII	17479518	17484965	-	XM_040196622.1	path1	Q9R1R0 O88706 Q6P1H2 Q9R1R1	LIM/homeobox protein Lhx6	LIM/homeobox protein Lhx6.1;	 PF00046;PF00412;	 GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0048469;GO:0021853;GO:0021895;GO:0021799;GO:0021800;GO:0021884;GO:0021877;GO:0030182;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:cell maturation; P:cerebral cortex GABAergic interneuron migration; P:cerebral cortex neuron differentiation; P:cerebral cortex radially oriented cell migration; P:cerebral cortex tangential migration; P:forebrain neuron development; P:forebrain neuron fate commitment; P:neuron differentiation; P:regulation of transcription by RNA polymerase II;
XM_040196285.1	chrXIII	17504292	17504292	chrXIII	17495802	17502159	+	XM_040196285.1	path1	O97554	Prostaglandin G/H synthase 1	Cyclooxygenase-1;Prostaglandin H2 synthase 1;Prostaglandin-endoperoxide synthase 1;	 PF03098;PF00008;	 GO:0005789;GO:0051213;GO:0020037;GO:0046872;GO:0004601;GO:0004666;GO:0019371;GO:0006954;GO:0008217;GO:0006979;	  C:endoplasmic reticulum membrane;	  F:dioxygenase activity; F:heme binding; F:metal ion binding; F:peroxidase activity; F:prostaglandin-endoperoxide synthase activity;	  P:cyclooxygenase pathway; P:inflammatory response; P:regulation of blood pressure; P:response to oxidative stress;
XM_040196282.1	chrXIII	17504292	17504292	chrXIII	17502782	17513421	-	XM_040196282.1	path1	D3YXG0 D3Z2Q7	Hemicentin-1 {ECO:0000312|MGI:MGI:2685047}	Fibulin-6 {ECO:0000303|PubMed:24951538};	 PF12662;PF07645;PF07474;PF07679;PF00090;	 GO:0005912;GO:0005604;GO:0005938;GO:0030054;GO:0032154;GO:0062023;GO:0005576;GO:0005509;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;	  C:adherens junction; C:basement membrane; C:cell cortex; C:cell junction; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular region;	  F:calcium ion binding;	  P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium;
XM_040195754.1	chrXIII	17504292	17504292	chrXIII	17515144	17520268	+	XM_040195754.1	path1	Q10713 B4DKL3 E7ET61 Q16639 Q5SXM9 Q8N513	Mitochondrial-processing peptidase subunit alpha	Alpha-MPP;Inactive zinc metalloprotease alpha {ECO:0000305};P-55;	 PF00675;PF05193;	 GO:0005615;GO:0005743;GO:0005759;GO:0005739;GO:0046872;GO:0006851;GO:0006627;	  C:extracellular space; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;	  F:metal ion binding;	  P:mitochondrial calcium ion transmembrane transport; P:protein processing involved in protein targeting to mitochondrion;
XM_040195752.1	chrXIII	17504292	17504292	chrXIII	17520299	17524700	-	XM_040195752.1	path1	Q9WVR1 A0A0G2K6T4	Phosphatidylinositol polyphosphate 5-phosphatase type IV	5-phosphatase that induces arborization {ECO:0000303|PubMed:10405344};72 kDa inositol polyphosphate 5-phosphatase;Inositol polyphosphate-5-phosphatase E;Phosphatidylinositol 4,5-bisphosphate 5-phosphatase;Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase;	 PF03372;	 GO:0005930;GO:0005929;GO:0005737;GO:0005925;GO:0032580;GO:0000139;GO:0005654;GO:0005634;GO:0005886;GO:0001726;GO:0004445;GO:0016314;GO:0034485;GO:0004439;GO:0106019;GO:0046855;GO:0014067;GO:1903565;GO:0017148;GO:0046856;GO:0046488;	  C:axoneme; C:cilium; C:cytoplasm; C:focal adhesion; C:Golgi cisterna membrane; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle;	  F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate phosphatase activity;	  P:inositol phosphate dephosphorylation; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein localization to cilium; P:negative regulation of translation; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process;
XM_040195350.1	chrXIII	17587384	17587384	chrXIII	17553464	17586728	+	XM_040195350.1	path1	A2RUV0 F7CY31	Neurogenic locus notch homolog protein 1		 PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;	 GO:0016021;GO:0005634;GO:0005886;GO:0005509;GO:0005112;GO:0038023;GO:0001525;GO:0030154;GO:0060271;GO:0061314;GO:0007219;GO:0050793;GO:0006355;	  C:integral component of membrane; C:nucleus; C:plasma membrane;	  F:calcium ion binding; F:Notch binding; F:signaling receptor activity;	  P:angiogenesis; P:cell differentiation; P:cilium assembly; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:regulation of developmental process; P:regulation of transcription, DNA-templated;
XM_040196348.1	chrXIII	17587384	17587384	chrXIII	17587726	17593713	+	XM_040196348.1	path1	Q5ZJI9	Ubiquitin-associated domain-containing protein 1	E3 ubiquitin-protein ligase subunit KPC2;Kip1 ubiquitination-promoting complex protein 2;	 PF00627;	 GO:0005737;GO:0016567;	  C:cytoplasm;	 	  P:protein ubiquitination;
XM_040196312.1	chrXIII	17587384	17587384	chrXIII	17594547	17615207	+	XM_040196312.1	path1	A5WUN7	Calmodulin-regulated spectrin-associated protein 1-B		 PF17095;PF11971;PF08683;	 GO:0005737;GO:0005874;GO:0005516;GO:0008017;GO:0051011;GO:0030507;GO:0031122;GO:0007010;GO:0000226;GO:0007026;GO:0031175;GO:0022604;GO:0031113;	  C:cytoplasm; C:microtubule;	  F:calmodulin binding; F:microtubule binding; F:microtubule minus-end binding; F:spectrin binding;	  P:cytoplasmic microtubule organization; P:cytoskeleton organization; P:microtubule cytoskeleton organization; P:negative regulation of microtubule depolymerization; P:neuron projection development; P:regulation of cell morphogenesis; P:regulation of microtubule polymerization;
XM_040196339.1	chrXIII	17587384	17587384	chrXIII	17618839	17651331	-	XM_040196339.1	path1	Q6ZPR4 B2RUK3 Q8C3E7	Potassium channel subfamily T member 1		 PF03493;PF07885;	 GO:0016021;GO:0005886;GO:0005228;GO:0015271;GO:0005267;GO:0006813;	  C:integral component of membrane; C:plasma membrane;	  F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity; F:potassium channel activity;	  P:potassium ion transport;
XM_040196350.1	chrXIII	17672721	17672721	chrXIII	17664820	17675071	-	XM_040196350.1	path1	Q6DFF6	Kelch-like protein 20		 PF07707;PF00651;PF01344;	 GO:0031463;GO:0005737;GO:0005829;GO:0048471;GO:0016605;GO:0005802;GO:0019964;GO:0004842;GO:0006895;GO:0043066;GO:0043161;GO:1990390;GO:0015031;GO:0016567;	  C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm; C:PML body; C:trans-Golgi network;	  F:interferon-gamma binding; F:ubiquitin-protein transferase activity;	  P:Golgi to endosome transport; P:negative regulation of apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K33-linked ubiquitination; P:protein transport; P:protein ubiquitination;
XM_040195466.1	chrXIII	17672721	17672721	chrXIII	17687426	17740210	+	XM_040195466.1	path1	A0MSJ1	Collagen alpha-1(XXVII) chain B		 PF01410;PF01391;	 GO:0005581;GO:0031012;GO:0005615;GO:0005201;GO:0046872;GO:0030282;GO:0030198;GO:0048570;GO:0001501;	  C:collagen trimer; C:extracellular matrix; C:extracellular space;	  F:extracellular matrix structural constituent; F:metal ion binding;	  P:bone mineralization; P:extracellular matrix organization; P:notochord morphogenesis; P:skeletal system development;
XM_040197980.1	chrXIV	2320057	2320057	chrXIV	2322116	2329764	+	XM_040197980.1	path1	Q9UHF1 B3KRP0 M9VTX9 Q5M7Y5 Q5VUD5 Q96EG0	Epidermal growth factor-like protein 7	Multiple epidermal growth factor-like domains protein 7;NOTCH4-like protein;Vascular endothelial statin;Zneu1;	 PF07974;PF07645;PF07546;	 GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0005509;GO:0005102;GO:0048856;GO:0001525;GO:0001568;GO:0007155;GO:0045746;GO:0001938;GO:0001570;	  C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;	  F:calcium ion binding; F:signaling receptor binding;	  P:anatomical structure development; P:angiogenesis; P:blood vessel development; P:cell adhesion; P:negative regulation of Notch signaling pathway; P:positive regulation of endothelial cell proliferation; P:vasculogenesis;
XM_040196837.1	chrXIV	3728199	3728199	chrXIV	3700659	3720417	+	XM_040196837.1	path1	Q92824 F5H2G7 Q13527 Q96EP4	Proprotein convertase subtilisin/kexin type 5	Proprotein convertase 5;Proprotein convertase 6;Subtilisin/kexin-like protease PC5;	 PF14843;PF01483;PF00082;PF16470;	 GO:0005576;GO:0005615;GO:0005794;GO:0005796;GO:0030173;GO:0016020;GO:0030141;GO:0005802;GO:0004175;GO:0008233;GO:0042277;GO:0004252;GO:0009952;GO:0007267;GO:0140447;GO:0007566;GO:0048566;GO:0048706;GO:0007507;GO:0001822;GO:0035108;GO:0032455;GO:0043043;GO:0016486;GO:0016485;GO:0051004;GO:0002001;GO:0030323;GO:0006465;GO:0019058;	  C:extracellular region; C:extracellular space; C:Golgi apparatus; C:Golgi lumen; C:integral component of Golgi membrane; C:membrane; C:secretory granule; C:trans-Golgi network;	  F:endopeptidase activity; F:peptidase activity; F:peptide binding; F:serine-type endopeptidase activity;	  P:anterior/posterior pattern specification; P:cell-cell signaling; P:cytokine precursor processing; P:embryo implantation; P:embryonic digestive tract development; P:embryonic skeletal system development; P:heart development; P:kidney development; P:limb morphogenesis; P:nerve growth factor processing; P:peptide biosynthetic process; P:peptide hormone processing; P:protein processing; P:regulation of lipoprotein lipase activity; P:renin secretion into blood stream; P:respiratory tube development; P:signal peptide processing; P:viral life cycle;
XM_040196842.1	chrXIV	3727929	3727929	chrXIV	3720439	3726315	-	XM_040196842.1	path1	Q5R4Q8	Protein prune homolog 2	BNIP2 motif-containing molecule at the C-terminal region 1;	 PF12496;PF13716;	 GO:0005737;GO:0006915;	  C:cytoplasm;	 	  P:apoptotic process;
XM_040196840.1	chrXIV	3727929	3727929	chrXIV	3727451	3733041	-	XM_040196840.1	path1	O95837 B1ALW3	Guanine nucleotide-binding protein subunit alpha-14		 PF00503;	 GO:0070062;GO:0005834;GO:0005886;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007188;GO:0007186;GO:0060158;GO:0030168;GO:0007165;	  C:extracellular exosome; C:heterotrimeric G-protein complex; C:plasma membrane;	  F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;	  P:action potential; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:phospholipase C-activating dopamine receptor signaling pathway; P:platelet activation; P:signal transduction;
XM_040196839.1	chrXIV	3727929	3727929	chrXIV	3733794	3742775	-	XM_040196839.1	path1	P50148 O15108 Q13462 Q6NT27 Q92471 Q9BZB9	Guanine nucleotide-binding protein G(q) subunit alpha	Guanine nucleotide-binding protein alpha-q;	 PF00503;	 GO:0005737;GO:0070062;GO:0005794;GO:0005834;GO:0005765;GO:0031965;GO:0001750;GO:0005886;GO:0045202;GO:0001664;GO:0031683;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007202;GO:0007189;GO:0007188;GO:0007596;GO:0009649;GO:0007213;GO:0007186;GO:0007215;GO:0006469;GO:0007603;GO:0030168;GO:0050821;GO:0060828;	  C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:nuclear membrane; C:photoreceptor outer segment; C:plasma membrane; C:synapse;	  F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;	  P:action potential; P:activation of phospholipase C activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:blood coagulation; P:entrainment of circadian clock; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glutamate receptor signaling pathway; P:negative regulation of protein kinase activity; P:phototransduction, visible light; P:platelet activation; P:protein stabilization; P:regulation of canonical Wnt signaling pathway;
XM_040197298.1	chrXIV	3781839	3781839	chrXIV	3770000	3774952	-	XM_040197298.1	path1	Q7T321	E3 ubiquitin-protein ligase KCMF1	RING-type E3 ubiquitin transferase KCMF1 {ECO:0000305};	 PF05605;PF00569;	 GO:0005886;GO:0045202;GO:0061630;GO:0008270;GO:0099536;	  C:plasma membrane; C:synapse;	  F:ubiquitin protein ligase activity; F:zinc ion binding;	  P:synaptic signaling;
XM_040197929.1	chrXIV	3781839	3781839	chrXIV	3777086	3805038	-	XM_040197929.1	path1	P56199 B2RNU0	Integrin alpha-1	CD49 antigen-like family member A;Laminin and collagen receptor;VLA-1;	 PF01839;PF08441;PF00092;	 GO:0001669;GO:0045178;GO:0009986;GO:0009897;GO:0070062;GO:0005925;GO:0034665;GO:0008305;GO:0016020;GO:0045121;GO:0043005;GO:0043204;GO:0005886;GO:0005518;GO:0098639;GO:0046872;GO:0019903;GO:0005102;GO:0000187;GO:0007160;GO:0045123;GO:0030198;GO:0007229;GO:0006936;GO:0008285;GO:0042059;GO:0048812;GO:0030593;GO:0043525;GO:0032516;GO:0042311;	  C:acrosomal vesicle; C:basal part of cell; C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integrin alpha1-beta1 complex; C:integrin complex; C:membrane; C:membrane raft; C:neuron projection; C:perikaryon; C:plasma membrane;	  F:collagen binding; F:collagen binding involved in cell-matrix adhesion; F:metal ion binding; F:protein phosphatase binding; F:signaling receptor binding;	  P:activation of MAPK activity; P:cell-matrix adhesion; P:cellular extravasation; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:muscle contraction; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:neuron projection morphogenesis; P:neutrophil chemotaxis; P:positive regulation of neuron apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:vasodilation;
XM_040197993.1	chrXIV	3837660	3837660	chrXIV	3824374	3830086	+	XM_040197993.1	path1	Q9H939	Proline-serine-threonine phosphatase-interacting protein 2		 PF00611;	 GO:0005884;GO:0005737;GO:0005856;GO:0005829;GO:0005886;GO:0051015;GO:0030041;GO:0016477;	  C:actin filament; C:cytoplasm; C:cytoskeleton; C:cytosol; C:plasma membrane;	  F:actin filament binding;	  P:actin filament polymerization; P:cell migration;
XM_040197990.1	chrXIV	3837660	3837660	chrXIV	3830238	3838281	-	XM_040197990.1	path1	Q6PGC1 Q8BQJ4 Q8BT01 Q8C9B7 Q8C9H9	ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068}	DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};	 PF00270;PF04408;PF00271;PF07717;	 GO:0022627;GO:0016282;GO:0005739;GO:0005524;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;	  C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex; C:mitochondrion;	  F:ATP binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;	  P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;
XM_040198246.1	chrXIV	3837660	3837660	chrXIV	3838354	3839109	+	XM_040198246.1	path1	Q9CZU3	Exosome RNA helicase MTR4 {ECO:0000305}	ATP-dependent helicase SKIV2L2;Superkiller viralicidic activity 2-like 2;TRAMP-like complex helicase;	 PF00270;PF08148;PF00271;PF13234;	 GO:0071013;GO:0000176;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0003723;GO:0003724;GO:0006974;GO:0000460;GO:0006397;GO:0006401;GO:0008380;GO:0006364;	  C:catalytic step 2 spliceosome; C:nuclear exosome (RNase complex); C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;	  F:ATP binding; F:RNA binding; F:RNA helicase activity;	  P:cellular response to DNA damage stimulus; P:maturation of 5.8S rRNA; P:mRNA processing; P:RNA catabolic process; P:RNA splicing; P:rRNA processing;
XM_040197992.1	chrXIV	3837660	3837660	chrXIV	3839631	3850969	+	XM_040197992.1	path1	P42285 Q2M386 Q6MZZ8 Q6P170 Q8N5R0 Q8TAG2	Exosome RNA helicase MTR4 {ECO:0000305}	ATP-dependent RNA helicase DOB1 {ECO:0000303|PubMed:16782053};ATP-dependent RNA helicase SKIV2L2;Superkiller viralicidic activity 2-like 2;TRAMP-like complex helicase;	 PF00270;PF08148;PF00271;PF13234;	 GO:0071013;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0003723;GO:0003724;GO:0006974;GO:0000460;GO:0000398;GO:0006401;GO:0006364;GO:0016076;	  C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;	  F:ATP binding; F:RNA binding; F:RNA helicase activity;	  P:cellular response to DNA damage stimulus; P:maturation of 5.8S rRNA; P:mRNA splicing, via spliceosome; P:RNA catabolic process; P:rRNA processing; P:snRNA catabolic process;
XM_040197218.1	chrXIV	3912074	3912074	chrXIV	3881490	3902478	-	XM_040197218.1	path1	Q8TDX6 B2RBE4 Q6P9G6 Q8IUF9 Q9NSQ7 Q9NUM9	Chondroitin sulfate N-acetylgalactosaminyltransferase 1 {ECO:0000305}	Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1;	 PF05679;	 GO:0032580;GO:0000139;GO:0030173;GO:0008376;GO:0047238;GO:0015020;GO:0047237;GO:0046872;GO:0008955;GO:0051216;GO:0030206;GO:0050650;GO:0050653;GO:0050651;GO:0001958;GO:0030198;GO:0015014;GO:0030210;GO:0030166;GO:0046398;GO:0019276;	  C:Golgi cisterna membrane; C:Golgi membrane; C:integral component of Golgi membrane;	  F:acetylgalactosaminyltransferase activity; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:glucuronosyltransferase activity; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; F:metal ion binding; F:peptidoglycan glycosyltransferase activity;	  P:cartilage development; P:chondroitin sulfate biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process; P:chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:dermatan sulfate proteoglycan biosynthetic process; P:endochondral ossification; P:extracellular matrix organization; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin biosynthetic process; P:proteoglycan biosynthetic process; P:UDP-glucuronate metabolic process; P:UDP-N-acetylgalactosamine metabolic process;
XM_040197224.1	chrXIV	3912074	3912074	chrXIV	3904074	3906308	-	XM_040197224.1	path1	Q9D531 Q91WB0	Nucleoredoxin-like protein 2	Rod-derived cone viability factor 2;	 PF13905;	 GO:0045494;GO:0007608;GO:0007601;	 	 	  P:photoreceptor cell maintenance; P:sensory perception of smell; P:visual perception;
XM_040197226.1	chrXIV	3912074	3912074	chrXIV	3906431	3908503	+	XM_040197226.1	path1	P50151 Q3B7K2 Q4VC27	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10		 PF00631;	 GO:0031680;GO:0005834;GO:0005886;GO:0031681;GO:0003924;GO:0007186;GO:0007165;	  C:G-protein beta/gamma-subunit complex; C:heterotrimeric G-protein complex; C:plasma membrane;	  F:G-protein beta-subunit binding; F:GTPase activity;	  P:G protein-coupled receptor signaling pathway; P:signal transduction;
XM_040197222.1	chrXIV	3912074	3912074	chrXIV	3908912	3914142	+	XM_040197222.1	path1	P35070 Q96F48	Probetacellulin		 	 GO:0030669;GO:0005576;GO:0005615;GO:0016021;GO:0005886;GO:0005154;GO:0008083;GO:0007173;GO:0038128;GO:0000165;GO:0061024;GO:0043066;GO:0042059;GO:0045597;GO:0051781;GO:0008284;GO:0045741;GO:0048146;GO:0045840;GO:0051897;GO:0035810;GO:2000145;GO:0007165;	  C:clathrin-coated endocytic vesicle membrane; C:extracellular region; C:extracellular space; C:integral component of membrane; C:plasma membrane;	  F:epidermal growth factor receptor binding; F:growth factor activity;	  P:epidermal growth factor receptor signaling pathway; P:ERBB2 signaling pathway; P:MAPK cascade; P:membrane organization; P:negative regulation of apoptotic process; P:negative regulation of epidermal growth factor receptor signaling pathway; P:positive regulation of cell differentiation; P:positive regulation of cell division; P:positive regulation of cell population proliferation; P:positive regulation of epidermal growth factor-activated receptor activity; P:positive regulation of fibroblast proliferation; P:positive regulation of mitotic nuclear division; P:positive regulation of protein kinase B signaling; P:positive regulation of urine volume; P:regulation of cell motility; P:signal transduction;
XM_040197220.1	chrXIV	3912074	3912074	chrXIV	3915206	3917042	+	XM_040197220.1	path1	Q9NSD7 Q14DA5	Relaxin-3 receptor 1	G protein-coupled receptor SALPR;G-protein coupled receptor GPCR135;Relaxin family peptide receptor 3;Somatostatin- and angiotensin-like peptide receptor;	 PF00001;	 GO:0005887;GO:0005886;GO:0008528;GO:0004930;GO:0007186;GO:0007218;GO:0032467;	  C:integral component of plasma membrane; C:plasma membrane;	  F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity;	  P:G protein-coupled receptor signaling pathway; P:neuropeptide signaling pathway; P:positive regulation of cytokinesis;
XM_040197219.1	chrXIV	3912074	3912074	chrXIV	3919212	3927846	-	XM_040197219.1	path1	P58355	Membrane-associated transporter protein	Melanoma antigen AIM1;Protein underwhite;Solute carrier family 45 member 2;	 PF07690;	 GO:0016021;GO:0033162;GO:0016020;GO:0008506;GO:0048066;GO:0042438;GO:0050896;GO:0015770;GO:0007601;	  C:integral component of membrane; C:melanosome membrane; C:membrane;	  F:sucrose:proton symporter activity;	  P:developmental pigmentation; P:melanin biosynthetic process; P:response to stimulus; P:sucrose transport; P:visual perception;
XM_040197051.1	chrXIV	4036199	4036199	chrXIV	4023540	4028664	-	XM_040197051.1	path1	Q6NV26 Q8JHJ0	Protein SDA1 homolog	SDA1 domain-containing protein 1;	 PF08158;PF05285;	 GO:0005730;GO:0030036;GO:0042273;GO:0000055;	  C:nucleolus;	 	  P:actin cytoskeleton organization; P:ribosomal large subunit biogenesis; P:ribosomal large subunit export from nucleus;
XM_040197052.1	chrXIV	4036199	4036199	chrXIV	4029724	4051184	-	XM_040197052.1	path1	Q12923 B2RTR0 Q15159 Q15263 Q15264 Q15265 Q15674 Q16826 Q8IWH7 Q9NYN9 Q9UDA8	Tyrosine-protein phosphatase non-receptor type 13	Fas-associated protein-tyrosine phosphatase 1;PTP-BAS;Protein-tyrosine phosphatase 1E;Protein-tyrosine phosphatase PTPL1;	 PF09380;PF00373;PF09379;PF00595;PF00102;	 GO:0044297;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0001650;GO:0030027;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0036312;GO:0004725;GO:0071345;GO:0001933;GO:0035335;GO:0006661;GO:0006470;GO:0014066;	  C:cell body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:fibrillar center; C:lamellipodium; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane;	  F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein tyrosine phosphatase activity;	  P:cellular response to cytokine stimulus; P:negative regulation of protein phosphorylation; P:peptidyl-tyrosine dephosphorylation; P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling;
XM_040196892.1	chrXIV	4068483	4068483	chrXIV	4066983	4091173	+	XM_040196892.1	path1	P53779 A6NFS3 A6NG28 B3KQ94 Q15707 Q49AP1	Mitogen-activated protein kinase 10	MAP kinase p49 3F12;Stress-activated protein kinase 1b;Stress-activated protein kinase JNK3;c-Jun N-terminal kinase 3;	 PF00069;	 GO:0005737;GO:0005829;GO:0005739;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0004705;GO:0004707;GO:0004708;GO:0106310;GO:0004674;GO:0106311;GO:0038095;GO:0035556;GO:0007254;GO:0006468;GO:0042752;GO:0051090;GO:0009416;GO:0048511;GO:0007165;	  C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleoplasm; C:nucleus; C:plasma membrane;	  F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:MAP kinase kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:Fc-epsilon receptor signaling pathway; P:intracellular signal transduction; P:JNK cascade; P:protein phosphorylation; P:regulation of circadian rhythm; P:regulation of DNA-binding transcription factor activity; P:response to light stimulus; P:rhythmic process; P:signal transduction;
XM_040196889.1	chrXIV	4107366	4107366	chrXIV	4091693	4102186	-	XM_040196889.1	path1	Q8N264 Q4KMG1 Q6ZNV3 Q86TI5 Q86WE4 Q9H0T6	Rho GTPase-activating protein 24	Filamin-A-associated RhoGAP;RAC1- and CDC42-specific GTPase-activating protein of 72 kDa;Rho-type GTPase-activating protein 24;RhoGAP of 73 kDa;Sarcoma antigen NY-SAR-88;p73RhoGAP;	 PF00169;PF00620;	 GO:0005912;GO:0042995;GO:0005856;GO:0005829;GO:0005925;GO:0005096;GO:0090630;GO:0001525;GO:0030154;GO:0035021;GO:1900028;GO:0051056;GO:0007165;GO:0035313;	  C:adherens junction; C:cell projection; C:cytoskeleton; C:cytosol; C:focal adhesion;	  F:GTPase activator activity;	  P:activation of GTPase activity; P:angiogenesis; P:cell differentiation; P:negative regulation of Rac protein signal transduction; P:negative regulation of ruffle assembly; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:wound healing, spreading of epidermal cells;
XM_040197137.1	chrXIV	4136827	4136827	chrXIV	4140705	4142507	-	XM_040197137.1	path1	P97682	Endothelial cell-specific molecule 1	PG25;	 PF00219;	 GO:0005576;GO:0005171;GO:0005520;GO:0005178;GO:0001525;GO:0008284;GO:1902204;GO:0002040;	  C:extracellular region;	  F:hepatocyte growth factor receptor binding; F:insulin-like growth factor binding; F:integrin binding;	  P:angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of hepatocyte growth factor receptor signaling pathway; P:sprouting angiogenesis;
XM_040197130.1	chrXIV	4136827	4136827	chrXIV	4142836	4177170	+	XM_040197130.1	path1	Q15751 Q8IW65	Probable E3 ubiquitin-protein ligase HERC1	HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;	 PF00632;PF00415;PF00622;PF00400;	 GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;	  C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;	  F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;	  P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;
XM_040197322.1	chrXIV	6762760	6762760	chrXIV	6737533	6767480	-	XM_040197322.1	path1	Q0VA16	WD repeat-containing protein 70		 PF00400;	 GO:0005634;GO:0035861;GO:1903775;GO:2001173;	  C:nucleus; C:site of double-strand break;	 	  P:regulation of DNA double-strand break processing; P:regulation of histone H2B conserved C-terminal lysine ubiquitination;
XM_040197316.1	chrXIV	6762760	6762760	chrXIV	6767773	6784674	-	XM_040197316.1	path1	Q8CE72 E9QL36 Q3UXY6 Q6PEE0	Ciliogenesis and planar polarity effector 1 {ECO:0000305}	Protein C5orf42 homolog;Protein JBTS17 {ECO:0000303|PubMed:25877302, ECO:0000303|PubMed:27158779};	 PF15392;	 GO:0035869;GO:0016021;GO:0003279;GO:0021549;GO:0060271;GO:0060976;GO:0042733;GO:0001736;GO:0007507;GO:0001822;GO:1904491;GO:0060021;GO:0003281;	  C:ciliary transition zone; C:integral component of membrane;	 	  P:cardiac septum development; P:cerebellum development; P:cilium assembly; P:coronary vasculature development; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:heart development; P:kidney development; P:protein localization to ciliary transition zone; P:roof of mouth development; P:ventricular septum development;
XM_040198112.1	chrXIV	6942125	6942125	chrXIV	6915922	6922850	-	XM_040198112.1	path1	Q9UGT4 Q9H5Y6	Sushi domain-containing protein 2		 PF03782;PF01033;PF00084;PF00094;	 GO:0070062;GO:0005615;GO:0016021;GO:0005886;GO:1902807;GO:0051782;	  C:extracellular exosome; C:extracellular space; C:integral component of membrane; C:plasma membrane;	 	  P:negative regulation of cell cycle G1/S phase transition; P:negative regulation of cell division;
XM_040198583.1	chrXIV	6942125	6942125	chrXIV	6923900	6932914	-	XM_040198583.1	path1	Q8N1T3 F5H3C6	Unconventional myosin-Ih	Myosin-1H;	 PF00063;PF06017;	 GO:0015629;GO:0005737;GO:0005902;GO:0016459;GO:0005886;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0000146;GO:0007015;GO:0030050;	  C:actin cytoskeleton; C:cytoplasm; C:microvillus; C:myosin complex; C:plasma membrane; C:vesicle;	  F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:microfilament motor activity;	  P:actin filament organization; P:vesicle transport along actin filament;
XM_040197706.1	chrXIV	6942125	6942125	chrXIV	6943434	6957374	+	XM_040197706.1	path1	Q76I79 Q3TDG3 Q69ZM4 Q811E5	Protein phosphatase Slingshot homolog 1	SSH-like protein 1;	 PF08766;	 GO:0031252;GO:0042995;GO:0032154;GO:0005737;GO:0005856;GO:0005829;GO:0030426;GO:0030496;GO:0005886;GO:0045202;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0000902;GO:0071318;GO:0098976;GO:0030837;GO:1904719;GO:2000463;GO:1901216;GO:0031915;GO:1904754;GO:0006470;GO:0032268;	  C:cell leading edge; C:cell projection; C:cleavage furrow; C:cytoplasm; C:cytoskeleton; C:cytosol; C:growth cone; C:midbody; C:plasma membrane; C:synapse;	  F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;	  P:actin cytoskeleton organization; P:cell morphogenesis; P:cellular response to ATP; P:excitatory chemical synaptic transmission; P:negative regulation of actin filament polymerization; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron death; P:positive regulation of synaptic plasticity; P:positive regulation of vascular associated smooth muscle cell migration; P:protein dephosphorylation; P:regulation of cellular protein metabolic process;
XM_040197701.1	chrXIV	6942125	6942125	chrXIV	6960009	6971398	+	XM_040197701.1	path1	B0R0D7 Q7ZW06	Coronin-1C-A {ECO:0000305}		 PF08953;PF00400;	 GO:0015629;GO:0005938;GO:0010008;GO:0030027;GO:0032587;GO:0051015;GO:0007015;GO:0016477;GO:0016197;GO:0140285;GO:0097750;GO:0090148;GO:0001755;	  C:actin cytoskeleton; C:cell cortex; C:endosome membrane; C:lamellipodium; C:ruffle membrane;	  F:actin filament binding;	  P:actin filament organization; P:cell migration; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:membrane fission; P:neural crest cell migration;
XM_040198189.1	chrXIV	6953837	6953837	chrXIV	6975823	6978082	+	XM_040198189.1	path1	Q4V9L6 Q6UXE5 Q8N2F5	Transmembrane protein 119	Osteoblast induction factor;	 PF15724;	 GO:0005789;GO:0016021;GO:0005886;GO:0031214;GO:0001958;GO:0045779;GO:0010832;GO:0001649;GO:1903012;GO:0030501;GO:0010628;GO:0045669;GO:0033690;GO:0001934;GO:0048515;GO:0007283;	  C:endoplasmic reticulum membrane; C:integral component of membrane; C:plasma membrane;	 	  P:biomineral tissue development; P:endochondral ossification; P:negative regulation of bone resorption; P:negative regulation of myotube differentiation; P:osteoblast differentiation; P:positive regulation of bone development; P:positive regulation of bone mineralization; P:positive regulation of gene expression; P:positive regulation of osteoblast differentiation; P:positive regulation of osteoblast proliferation; P:positive regulation of protein phosphorylation; P:spermatid differentiation; P:spermatogenesis;
XM_040196937.1	chrXIV	11242475	11242475	chrXIV	11217311	11233582	+	XM_040196937.1	path1	Q9H9B1 B1AQ58 B1AQ59 Q86X08 Q8TCN7 Q96F53 Q96JF1 Q96KH4	Histone-lysine N-methyltransferase EHMT1	Euchromatic histone-lysine N-methyltransferase 1;G9a-like protein 1;Histone H3-K9 methyltransferase 5;Lysine N-methyltransferase 1D;	 PF12796;PF05033;PF00856;	 GO:0005694;GO:0016604;GO:0005654;GO:0005634;GO:0070742;GO:0046976;GO:0046974;GO:0018024;GO:0008168;GO:0002039;GO:0016279;GO:0001226;GO:0008270;GO:0006325;GO:0006306;GO:0016571;GO:0070317;GO:0000122;GO:0045892;GO:0018027;GO:0018026;GO:0120162;GO:0045995;GO:1901796;GO:0060992;	  C:chromosome; C:nuclear body; C:nucleoplasm; C:nucleus;	  F:C2H2 zinc finger domain binding; F:histone methyltransferase activity (H3-K27 specific); F:histone methyltransferase activity (H3-K9 specific); F:histone-lysine N-methyltransferase activity; F:methyltransferase activity; F:p53 binding; F:protein-lysine N-methyltransferase activity; F:RNA polymerase II transcription corepressor binding; F:zinc ion binding;	  P:chromatin organization; P:DNA methylation; P:histone methylation; P:negative regulation of G0 to G1 transition; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:positive regulation of cold-induced thermogenesis; P:regulation of embryonic development; P:regulation of signal transduction by p53 class mediator; P:response to fungicide;
XM_040196944.1	chrXIV	11242475	11242475	chrXIV	11237623	11363424	+	XM_040196944.1	path1	Q05152	Voltage-dependent N-type calcium channel subunit alpha-1B	Brain calcium channel III;Calcium channel, L type, alpha-1 polypeptide isoform 5;Voltage-gated calcium channel subunit alpha Cav2.2;	 PF08763;PF16905;PF00520;	 GO:0009986;GO:0005891;GO:0005524;GO:0005509;GO:0005245;GO:0006816;GO:0034765;	  C:cell surface; C:voltage-gated calcium channel complex;	  F:ATP binding; F:calcium ion binding; F:voltage-gated calcium channel activity;	  P:calcium ion transport; P:regulation of ion transmembrane transport;
XM_040197907.1	chrXIV	13790433	13790433	chrXIV	13791686	13803379	-	XM_040197907.1	path1	Q6QMG1	Thyrotropin receptor {ECO:0000305}	Thyroid-stimulating hormone receptor {ECO:0000303|PubMed:19523396};	 PF00001;PF13306;PF13855;	 GO:0016323;GO:0016021;GO:0016020;GO:0005886;GO:0044877;GO:0038023;GO:0004996;GO:0007189;GO:0007166;GO:1904588;GO:1905229;GO:0007276;GO:0044752;GO:0097066;GO:0001501;GO:0038194;	  C:basolateral plasma membrane; C:integral component of membrane; C:membrane; C:plasma membrane;	  F:protein-containing complex binding; F:signaling receptor activity; F:thyroid-stimulating hormone receptor activity;	  P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:cellular response to glycoprotein; P:cellular response to thyrotropin-releasing hormone; P:gamete generation; P:response to human chorionic gonadotropin; P:response to thyroid hormone; P:skeletal system development; P:thyroid-stimulating hormone signaling pathway;
XM_040198784.1	chrXV	800537	800537	chrXV	790666	815558	-	XM_040198784.1	path1	Q07866 A6NF62 F8VTM4 Q7RTM2 Q7RTM3 Q7RTM5 Q7RTP9 Q7RTQ3 Q7RTQ5 Q7RTQ6 Q86SF5 Q86TF5 Q86V74 Q86V75 Q86V76 Q86V77 Q86V78 Q86V79 Q96H62	Kinesin light chain 1		 PF13176;	 GO:0031410;GO:0005829;GO:0030426;GO:0005871;GO:0016020;GO:0005874;GO:0003774;GO:0019886;GO:0007018;GO:0006890;GO:0035617;GO:0016032;	  C:cytoplasmic vesicle; C:cytosol; C:growth cone; C:kinesin complex; C:membrane; C:microtubule;	  F:motor activity;	  P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:microtubule-based movement; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:stress granule disassembly; P:viral process;
XM_040199173.1	chrXV	1227987	1227987	chrXV	1227929	1230050	+	XM_040199173.1	path1	P51779	Complement factor D	Adipsin;C3 convertase activator;Properdin factor D;	 PF00089;	 GO:0005615;GO:0004252;GO:0006957;GO:0007219;GO:0009617;	  C:extracellular space;	  F:serine-type endopeptidase activity;	  P:complement activation, alternative pathway; P:Notch signaling pathway; P:response to bacterium;
XM_040199172.1	chrXV	1227987	1227987	chrXV	1229730	1232859	-	XM_040199172.1	path1	Q8NHV1	GTPase IMAP family member 7	Immunity-associated nucleotide 7 protein;	 PF04548;	 GO:0005829;GO:0005783;GO:0005794;GO:0043231;GO:0005811;GO:0005525;GO:0003924;GO:0042802;GO:0042803;GO:0046039;	  C:cytosol; C:endoplasmic reticulum; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:lipid droplet;	  F:GTP binding; F:GTPase activity; F:identical protein binding; F:protein homodimerization activity;	  P:GTP metabolic process;
XM_040199693.1	chrXV	9097660	9097660	chrXV	9076009	9087852	-	XM_040199693.1	path1	Q06HQ7	Phospholipase B1, membrane-associated	Lysophospholipase;Phospholipase A2;Phospholipase B/lipase;Triacylglycerol lipase;	 PF00657;	 GO:0016324;GO:0031526;GO:0016021;GO:0004622;GO:0102545;GO:0004623;GO:0102567;GO:0102568;GO:0004620;GO:0050253;GO:0004806;GO:0006644;	  C:apical plasma membrane; C:brush border membrane; C:integral component of membrane;	  F:lysophospholipase activity; F:phosphatidyl phospholipase B activity; F:phospholipase A2 activity; F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine); F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine); F:phospholipase activity; F:retinyl-palmitate esterase activity; F:triglyceride lipase activity;	  P:phospholipid metabolic process;
XM_040199545.1	chrXV	9097660	9097660	chrXV	9089197	9092349	+	XM_040199545.1	path1	P62699 D6W568 Q65Z97 Q8R174 Q9D6M1 Q9UMX7 Q9Y3C9	Protein yippee-like 5		 PF03226;	 GO:0005576;GO:1904813;GO:0005815;GO:0030496;GO:0097431;GO:0005634;GO:1904724;GO:0000151;GO:0046872;GO:0008283;GO:0043312;	  C:extracellular region; C:ficolin-1-rich granule lumen; C:microtubule organizing center; C:midbody; C:mitotic spindle pole; C:nucleus; C:tertiary granule lumen; C:ubiquitin ligase complex;	  F:metal ion binding;	  P:cell population proliferation; P:neutrophil degranulation;
XM_040199544.1	chrXV	9097660	9097660	chrXV	9094257	9100309	-	XM_040199544.1	path1	Q5F3X0	Lysocardiolipin acyltransferase 1	1-acylglycerol-3-phosphate O-acyltransferase 8 {ECO:0000250|UniProtKB:Q6UWP7};Acyl-CoA:lysocardiolipin acyltransferase 1 {ECO:0000250|UniProtKB:Q3UN02};	 PF16076;PF01553;	 GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0003841;GO:0016746;GO:0016024;GO:0007275;GO:0036149;	  C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;	  F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;	  P:CDP-diacylglycerol biosynthetic process; P:multicellular organism development; P:phosphatidylinositol acyl-chain remodeling;
XM_040199932.1	chrXV	9097660	9097660	chrXV	9109164	9116807	-	XM_040199932.1	path1	A5PJU8	Protein LBH		 PF15317;	 GO:0005737;GO:0005634;GO:0032991;GO:0007275;GO:0045892;GO:0045893;GO:0043408;	  C:cytoplasm; C:nucleus; C:protein-containing complex;	 	  P:multicellular organism development; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of MAPK cascade;
XM_040199509.1	chrXV	9218026	9218026	chrXV	9206024	9225180	+	XM_040199509.1	path1	O46606	Phospholipase DDHD1 {ECO:0000305}	DDHD domain-containing protein 1;Phosphatidic acid-preferring phospholipase A1;	 PF02862;	 GO:0005737;GO:0046872;GO:0004620;GO:0016042;	  C:cytoplasm;	  F:metal ion binding; F:phospholipase activity;	  P:lipid catabolic process;
XM_040199638.1	chrXV	9218026	9218026	chrXV	9227402	9260913	+	XM_040199638.1	path1	F1Q8X5 Q58EF4	Fermitin family homolog 2	Kindlin-2;	 PF00373;PF18124;PF00169;	 GO:0005938;GO:0009986;GO:0030055;GO:0005856;GO:0031234;GO:0005925;GO:0031674;GO:0014704;GO:0031258;GO:0005634;GO:0005178;GO:0008289;GO:0001525;GO:0055008;GO:0016477;GO:0007160;GO:0007010;GO:0007229;GO:0008360;GO:0016055;	  C:cell cortex; C:cell surface; C:cell-substrate junction; C:cytoskeleton; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:I band; C:intercalated disc; C:lamellipodium membrane; C:nucleus;	  F:integrin binding; F:lipid binding;	  P:angiogenesis; P:cardiac muscle tissue morphogenesis; P:cell migration; P:cell-matrix adhesion; P:cytoskeleton organization; P:integrin-mediated signaling pathway; P:regulation of cell shape; P:Wnt signaling pathway;
XM_040200245.1	chrXV	11786863	11786863	chrXV	11748856	11758114	-	XM_040200245.1	path1	Q6EUW1 Q5XG59	Forkhead box protein O3 {ECO:0000305}		 PF00250;PF16676;PF16675;	 GO:0005737;GO:0005829;GO:0005634;GO:0031490;GO:0001228;GO:0003700;GO:0019901;GO:0000978;GO:0043565;GO:0006915;GO:0034599;GO:0010508;GO:0014737;GO:0043525;GO:0045944;GO:0045893;GO:0006357;GO:0070542;GO:0042594;GO:0033209;	  C:cytoplasm; C:cytosol; C:nucleus;	  F:chromatin DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:protein kinase binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;	  P:apoptotic process; P:cellular response to oxidative stress; P:positive regulation of autophagy; P:positive regulation of muscle atrophy; P:positive regulation of neuron apoptotic process; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:response to fatty acid; P:response to starvation; P:tumor necrosis factor-mediated signaling pathway;
XM_040200268.1	chrXV	11782254	11782254	chrXV	11758232	11764562	-	XM_040200268.1	path1	Q8WV93 Q8N6A3	AFG1-like ATPase {ECO:0000312|HGNC:HGNC:16411}	Lactation elevated protein 1 {ECO:0000303|PubMed:12079282};Protein AFG1 homolog;	 PF03969;	 GO:0005737;GO:0031966;GO:0005739;GO:0005524;GO:0016887;GO:0006123;GO:0035694;GO:0007005;	  C:cytoplasm; C:mitochondrial membrane; C:mitochondrion;	  F:ATP binding; F:ATPase activity;	  P:mitochondrial electron transport, cytochrome c to oxygen; P:mitochondrial protein catabolic process; P:mitochondrion organization;
XM_040200272.1	chrXV	11782254	11782254	chrXV	11766214	11771490	+	XM_040200272.1	path1	Q8N228 B0QZ10 B0QZ11 B7ZBX3 Q5JXD0 Q5T0T6 Q8IYY6	Sex comb on midleg-like protein 4		 PF17208;PF00536;PF12140;	 GO:0005634;GO:0003682;GO:0042393;GO:0045892;	  C:nucleus;	  F:chromatin binding; F:histone binding;	  P:negative regulation of transcription, DNA-templated;
XM_040200285.1	chrXV	11782254	11782254	chrXV	11776340	11781829	+	XM_040200285.1	path1	P62760 D6W515 P28677 P29103 P42323 Q9UM20	Visinin-like protein 1	Hippocalcin-like protein 3;	 PF00036;PF13499;	 GO:0005829;GO:0016020;GO:0005509;GO:0046676;GO:0045921;GO:0035774;	  C:cytosol; C:membrane;	  F:calcium ion binding;	  P:negative regulation of insulin secretion; P:positive regulation of exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;
XM_040200214.1	chrXV	11782254	11782254	chrXV	11782440	11793388	-	XM_040200214.1	path1	Q6P9I7 Q805A0	Structural maintenance of chromosomes protein 6		 PF02463;	 GO:0000781;GO:0016605;GO:0030915;GO:0005524;GO:0090398;GO:0006281;GO:0000722;	  C:chromosome, telomeric region; C:PML body; C:Smc5-Smc6 complex;	  F:ATP binding;	  P:cellular senescence; P:DNA repair; P:telomere maintenance via recombination;
XM_040200202.1	chrXV	11782254	11782254	chrXV	11793392	11799191	+	XM_040200202.1	path1	F1R237 F1RE34	Tudor domain-containing 6 {ECO:0000305}		 PF00567;	 GO:0033391;GO:0060293;GO:0032019;GO:0043186;GO:0007281;GO:0070925;GO:1903863;GO:1905879;GO:0007283;	  C:chromatoid body; C:germ plasm; C:mitochondrial cloud; C:P granule;	 	  P:germ cell development; P:organelle assembly; P:P granule assembly; P:regulation of oogenesis; P:spermatogenesis;
XM_040200229.1	chrXV	11782258	11782258	chrXV	11800754	11807945	-	XM_040200229.1	path1	Q8IZF5 B4DF15 E9PEV1 Q53TA5 Q6UXT7 Q6UXX3 Q86SL7 Q8IXD8 Q8TDT3	Adhesion G-protein coupled receptor F3	G-protein coupled receptor 113;G-protein coupled receptor PGR23;	 PF00002;PF01825;	 GO:0016021;GO:0004930;GO:0007166;GO:0007186;	  C:integral component of membrane;	  F:G protein-coupled receptor activity;	  P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway;
XM_040199910.1	chrXV	11786349	11786349	chrXV	11808693	11815863	-	XM_040199910.1	path1	O70247	Sodium-dependent multivitamin transporter	Solute carrier family 5 member 6;	 PF00474;	 GO:0031526;GO:0016021;GO:0005886;GO:0012506;GO:0015225;GO:0015233;GO:0008523;GO:0015293;GO:1905135;GO:0015878;GO:1904200;GO:0015887;GO:0006814;GO:0150104;	  C:brush border membrane; C:integral component of membrane; C:plasma membrane; C:vesicle membrane;	  F:biotin transmembrane transporter activity; F:pantothenate transmembrane transporter activity; F:sodium-dependent multivitamin transmembrane transporter activity; F:symporter activity;	  P:biotin import across plasma membrane; P:biotin transport; P:iodide transmembrane transport; P:pantothenate transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier;
XM_040199912.1	chrXV	11812932	11812932	chrXV	11817147	11821237	+	XM_040199912.1	path1	Q28HU3 Q501R3	Centromere protein O		 PF09496;	 GO:0000778;GO:0031511;GO:0034508;	  C:condensed nuclear chromosome kinetochore; C:Mis6-Sim4 complex;	 	  P:centromere complex assembly;
XM_040199458.1	chrXV	11812932	11812932	chrXV	11821499	11825238	+	XM_040199458.1	path1	Q53FA7 D6W533 O14679 O14685 Q38G78 Q6JLE7 Q9BWB8	Quinone oxidoreductase PIG3	Tumor protein p53-inducible protein 3;p53-induced gene 3 protein;	 PF08240;PF00107;	 GO:0005829;GO:0070402;GO:0003960;GO:0042803;GO:0048038;GO:0006739;GO:0042981;	  C:cytosol;	  F:NADPH binding; F:NADPH:quinone reductase activity; F:protein homodimerization activity; F:quinone binding;	  P:NADP metabolic process; P:regulation of apoptotic process;
XM_040199457.1	chrXV	11812932	11812932	chrXV	11832259	11836289	+	XM_040199457.1	path1	Q2HJ10	Zinc transporter 2	Solute carrier family 30 member 2;	 PF01545;	 GO:0005737;GO:0031410;GO:0016021;GO:0043231;GO:0005770;GO:0005886;GO:0005774;GO:0042802;GO:0005385;GO:0061090;GO:0061088;GO:0010043;GO:0071577;GO:0006829;	  C:cytoplasm; C:cytoplasmic vesicle; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:plasma membrane; C:vacuolar membrane;	  F:identical protein binding; F:zinc ion transmembrane transporter activity;	  P:positive regulation of sequestering of zinc ion; P:regulation of sequestering of zinc ion; P:response to zinc ion; P:zinc ion transmembrane transport; P:zinc ion transport;
XM_040199456.1	chrXV	11812932	11812932	chrXV	11835741	11845205	-	XM_040199456.1	path1	Q5RGU1 G1K2I4 Q6DH95	Atypical kinase COQ8A, mitochondrial {ECO:0000305}	Chaperone activity of bc1 complex-like {ECO:0000250|UniProtKB:Q8NI60};Coenzyme Q protein 8A {ECO:0000250|UniProtKB:Q8NI60};aarF domain-containing protein kinase 3 {ECO:0000250|UniProtKB:Q8NI60};	 PF03109;	 GO:0031314;GO:0016021;GO:0005739;GO:0043531;GO:0005524;GO:0016301;GO:0016310;GO:0006468;GO:0006744;	  C:extrinsic component of mitochondrial inner membrane; C:integral component of membrane; C:mitochondrion;	  F:ADP binding; F:ATP binding; F:kinase activity;	  P:phosphorylation; P:protein phosphorylation; P:ubiquinone biosynthetic process;
XR_005714236.1	chrXV	12249627	12249627	chrXV	12225192	12233783	+	XR_005714236.1	path1	Q9HB21 B3KQ55 D3DRE2 Q9BVK0	Pleckstrin homology domain-containing family A member 1	Tandem PH domain-containing protein 1;	 PF00169;	 GO:0005737;GO:0005829;GO:0070062;GO:0016020;GO:0005654;GO:0005886;GO:0032587;GO:0008289;GO:0030165;GO:0043325;GO:0008209;GO:0050853;GO:0070301;GO:0045184;GO:0008210;GO:0060325;GO:0033327;GO:0001553;GO:0035264;GO:0051898;GO:0014065;GO:0006661;GO:0048008;GO:0009791;GO:0060021;GO:0031529;GO:0048705;GO:0007283;	  C:cytoplasm; C:cytosol; C:extracellular exosome; C:membrane; C:nucleoplasm; C:plasma membrane; C:ruffle membrane;	  F:lipid binding; F:PDZ domain binding; F:phosphatidylinositol-3,4-bisphosphate binding;	  P:androgen metabolic process; P:B cell receptor signaling pathway; P:cellular response to hydrogen peroxide; P:establishment of protein localization; P:estrogen metabolic process; P:face morphogenesis; P:Leydig cell differentiation; P:luteinization; P:multicellular organism growth; P:negative regulation of protein kinase B signaling; P:phosphatidylinositol 3-kinase signaling; P:phosphatidylinositol biosynthetic process; P:platelet-derived growth factor receptor signaling pathway; P:post-embryonic development; P:roof of mouth development; P:ruffle organization; P:skeletal system morphogenesis; P:spermatogenesis;
XM_040199096.1	chrXV	12249627	12249627	chrXV	12236568	12272182	+	XM_040199096.1	path1	Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7	Phosphofurin acidic cluster sorting protein 2	PACS1-like protein;	 PF10254;	 GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;	  C:endoplasmic reticulum; C:mitochondrion;	  F:ion channel binding;	  P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process;
XM_040199097.1	chrXV	12249627	12249627	chrXV	12275104	12288038	+	XM_040199097.1	path1	Q80T85 Q80VT3 Q80ZW6 Q8BIP8 Q8BVK5 Q8K0Q6	DDB1- and CUL4-associated factor 5	WD repeat-containing protein 22;	 PF00400;	 GO:0080008;GO:0005737;GO:0005739;GO:0016567;	  C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:mitochondrion;	 	  P:protein ubiquitination;
XM_040199381.1	chrXV	12275052	12275052	chrXV	12293679	12333174	+	XM_040199381.1	path1	Q2PFV7	Alpha-actinin-1	Alpha-actinin cytoskeletal isoform;F-actin cross-linking protein;Non-muscle alpha-actinin-1;	 PF00307;PF08726;PF00435;	 GO:0005923;GO:0031252;GO:0097433;GO:0005925;GO:0090637;GO:0030027;GO:0016328;GO:0090636;GO:0001726;GO:0042383;GO:0030486;GO:0001725;GO:1990357;GO:0030018;GO:0005915;GO:0003779;GO:0051393;GO:0005509;GO:0042803;GO:0017166;GO:0045214;GO:0048741;	  C:bicellular tight junction; C:cell leading edge; C:dense body; C:focal adhesion; C:inner dense plaque of desmosome; C:lamellipodium; C:lateral plasma membrane; C:outer dense plaque of desmosome; C:ruffle; C:sarcolemma; C:smooth muscle dense body; C:stress fiber; C:terminal web; C:Z disc; C:zonula adherens;	  F:actin binding; F:alpha-actinin binding; F:calcium ion binding; F:protein homodimerization activity; F:vinculin binding;	  P:sarcomere organization; P:skeletal muscle fiber development;
XM_040199162.1	chrXV	15225470	15225470	chrXV	15187657	15207635	-	XM_040199162.1	path1	Q8K2L8 E9QLQ6 Q8BX27	Trafficking protein particle complex subunit 12 {ECO:0000305}	Tetratricopeptide repeat protein 15 {ECO:0000250|UniProtKB:Q8WVT3};	 	 GO:0005793;GO:0005794;GO:0000776;GO:0005654;GO:0005634;GO:0048471;GO:0030008;GO:0006888;GO:0007030;GO:0051310;GO:1905342;GO:0090234;	  C:endoplasmic reticulum-Golgi intermediate compartment; C:Golgi apparatus; C:kinetochore; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:TRAPP complex;	 	  P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:metaphase plate congression; P:positive regulation of protein localization to kinetochore; P:regulation of kinetochore assembly;
XM_040200045.1	chrXV	15225470	15225470	chrXV	15207785	15245542	+	XM_040200045.1	path1	Q5XJP1	EARP-interacting protein homolog {ECO:0000250|UniProtKB:Q5PPK9}		 PF00400;	 GO:0005794;GO:0032456;GO:0016567;	  C:Golgi apparatus;	 	  P:endocytic recycling; P:protein ubiquitination;
XM_040199517.1	chrXV	15446661	15446661	chrXV	15406108	15442820	+	XM_040199517.1	path1	A4IGL7 Q5HZ61	Peroxidasin		 PF03098;PF07679;PF13855;PF00093;	 GO:0005615;GO:0020037;GO:0046872;GO:0004601;GO:0042744;GO:0006979;	  C:extracellular space;	  F:heme binding; F:metal ion binding; F:peroxidase activity;	  P:hydrogen peroxide catabolic process; P:response to oxidative stress;
XM_040198714.1	chrXV	15446661	15446661	chrXV	15453122	15456680	-	XM_040198714.1	path1	O54689	C-C chemokine receptor type 6	KY411;	 PF00001;	 GO:0009986;GO:0009897;GO:0016021;GO:0036126;GO:0097225;GO:0097524;GO:0097228;GO:0019957;GO:0016493;GO:0019722;GO:0060326;GO:0006935;GO:1904155;GO:1904156;GO:0006955;GO:0048290;GO:0002523;GO:0072676;GO:0007204;GO:2000510;GO:0010634;GO:0060474;GO:2000404;GO:0072678;GO:0072679;	  C:cell surface; C:external side of plasma membrane; C:integral component of membrane; C:sperm flagellum; C:sperm midpiece; C:sperm plasma membrane; C:sperm principal piece;	  F:C-C chemokine binding; F:C-C chemokine receptor activity;	  P:calcium-mediated signaling; P:cell chemotaxis; P:chemotaxis; P:DN2 thymocyte differentiation; P:DN3 thymocyte differentiation; P:immune response; P:isotype switching to IgA isotypes; P:leukocyte migration involved in inflammatory response; P:lymphocyte migration; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of dendritic cell chemotaxis; P:positive regulation of epithelial cell migration; P:positive regulation of flagellated sperm motility involved in capacitation; P:regulation of T cell migration; P:T cell migration; P:thymocyte migration;
XM_040202364.1	chrXVI	13384292	13384292	chrXVI	13393873	13399018	-	XM_040202364.1	path1	Q5RAL4	Syntaxin-19		 PF00804;	 GO:0005737;GO:0016021;GO:0005886;GO:0005484;GO:0006886;GO:0016192;	  C:cytoplasm; C:integral component of membrane; C:plasma membrane;	  F:SNAP receptor activity;	  P:intracellular protein transport; P:vesicle-mediated transport;
XM_040202470.1	chrXVI	14902915	14902915	chrXVI	14873837	14889520	+	XM_040202470.1	path1	P22727 Q80ZM9	Protein Wnt-6		 PF00110;	 GO:0009986;GO:0005788;GO:0031012;GO:0005615;GO:0005125;GO:0005109;GO:0005102;GO:0009887;GO:0009798;GO:0001658;GO:0060070;GO:0045165;GO:0007267;GO:0060684;GO:0072080;GO:0072079;GO:0030182;GO:0042475;GO:0010628;GO:0070172;GO:0045893;GO:0007165;GO:0016055;	  C:cell surface; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular space;	  F:cytokine activity; F:frizzled binding; F:signaling receptor binding;	  P:animal organ morphogenesis; P:axis specification; P:branching involved in ureteric bud morphogenesis; P:canonical Wnt signaling pathway; P:cell fate commitment; P:cell-cell signaling; P:epithelial-mesenchymal cell signaling; P:nephron tubule development; P:nephron tubule formation; P:neuron differentiation; P:odontogenesis of dentin-containing tooth; P:positive regulation of gene expression; P:positive regulation of tooth mineralization; P:positive regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;
XM_040202471.1	chrXVI	14902915	14902915	chrXVI	14898792	14915892	+	XM_040202471.1	path1	P43446	Protein Wnt-10a		 PF00110;	 GO:0005615;GO:0005125;GO:0005109;GO:0060070;GO:0045165;GO:0030182;GO:0042476;	  C:extracellular space;	  F:cytokine activity; F:frizzled binding;	  P:canonical Wnt signaling pathway; P:cell fate commitment; P:neuron differentiation; P:odontogenesis;
XM_040202159.1	chrXVI	14975319	14975319	chrXVI	14960273	14965685	-	XM_040202159.1	path1	A3FEM2	Protein FEV	Protein Pet-1;	 PF00178;	 GO:0005634;GO:0000981;GO:0000976;GO:0030154;GO:0060218;GO:0007399;GO:0006357;GO:0006355;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:transcription regulatory region sequence-specific DNA binding;	  P:cell differentiation; P:hematopoietic stem cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;
XM_040202155.1	chrXVI	14975319	14975319	chrXVI	14966764	14969432	-	XM_040202155.1	path1	P55164	Beta-crystallin A2	Beta-A2 crystallin;	 PF00030;	 GO:0005212;GO:0002088;GO:0007601;	 	  F:structural constituent of eye lens;	  P:lens development in camera-type eye; P:visual perception;
XM_040202033.1	chrXVI	14975319	14975319	chrXVI	14976882	14981271	-	XM_040202033.1	path1	P11172 B5LY68 B5LY72 O00758 O00759 O00760 Q16862 Q9H3Q2 Q9UG49	Uridine 5'-monophosphate synthase		 PF00215;PF00156;	 GO:0005737;GO:0005829;GO:0005634;GO:0042802;GO:0004588;GO:0004590;GO:0006207;GO:0044205;GO:0035690;GO:0007565;GO:0007595;GO:0019856;GO:0046134;GO:0006222;	  C:cytoplasm; C:cytosol; C:nucleus;	  F:identical protein binding; F:orotate phosphoribosyltransferase activity; F:orotidine-5'-phosphate decarboxylase activity;	  P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:cellular response to drug; P:female pregnancy; P:lactation; P:pyrimidine nucleobase biosynthetic process; P:pyrimidine nucleoside biosynthetic process; P:UMP biosynthetic process;
XM_040201713.1	chrXVI	14975319	14975319	chrXVI	14982859	15006759	-	XM_040201713.1	path1	P07589	Fibronectin {ECO:0000250|UniProtKB:P02751}		 PF00039;PF00040;PF00041;	 GO:0062023;GO:0005576;GO:0005615;GO:0097718;GO:0008201;GO:0005178;GO:0043394;GO:0005102;GO:0006953;GO:0001525;GO:0072378;GO:0007160;GO:0007044;GO:0007507;GO:0007399;GO:0070527;GO:0008360;	  C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;	  F:disordered domain specific binding; F:heparin binding; F:integrin binding; F:proteoglycan binding; F:signaling receptor binding;	  P:acute-phase response; P:angiogenesis; P:blood coagulation, fibrin clot formation; P:cell-matrix adhesion; P:cell-substrate junction assembly; P:heart development; P:nervous system development; P:platelet aggregation; P:regulation of cell shape;
XM_040202218.1	chrXVI	15073788	15073788	chrXVI	15065695	15199589	+	XM_040202218.1	path1	Q9CSB4 Q5SV53	Partitioning defective 3 homolog B	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein homolog;PAR3-beta;Partitioning defective 3-like protein;	 PF12053;PF00595;	 GO:0005912;GO:0043296;GO:0016324;GO:0005923;GO:0005938;GO:0030054;GO:0012505;GO:0032991;GO:0035091;GO:0007155;GO:0007049;GO:0051301;GO:0030010;GO:0051660;GO:0045197;GO:0000226;GO:0008104;	  C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:bicellular tight junction; C:cell cortex; C:cell junction; C:endomembrane system; C:protein-containing complex;	  F:phosphatidylinositol binding;	  P:cell adhesion; P:cell cycle; P:cell division; P:establishment of cell polarity; P:establishment of centrosome localization; P:establishment or maintenance of epithelial cell apical/basal polarity; P:microtubule cytoskeleton organization; P:protein localization;
XM_040204326.1	chrXVII	812046	812046	chrXVII	773763	855195	+	XM_040204326.1	path1	P35400	Metabotropic glutamate receptor 7		 PF00003;PF01094;PF07562;	 GO:0032279;GO:0030424;GO:0043679;GO:0005938;GO:0009986;GO:0030425;GO:0043198;GO:0098982;GO:0098978;GO:0005794;GO:0016021;GO:0005887;GO:0099059;GO:0099056;GO:0016020;GO:0043025;GO:0045211;GO:0048786;GO:0042734;GO:0032991;GO:0043235;GO:0005791;GO:0045202;GO:0043195;GO:0001640;GO:0005246;GO:0048306;GO:0005516;GO:0016595;GO:0008066;GO:0001642;GO:0042802;GO:0030165;GO:0070905;GO:0005245;GO:0007196;GO:0030534;GO:0008306;GO:0001662;GO:0007268;GO:0001661;GO:0007216;GO:0007611;GO:0007613;GO:0033555;GO:0014050;GO:0043524;GO:0050877;GO:0051966;GO:2000300;GO:0007605;GO:0007614;GO:0019226;	  C:asymmetric synapse; C:axon; C:axon terminus; C:cell cortex; C:cell surface; C:dendrite; C:dendritic shaft; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:integral component of presynaptic membrane; C:membrane; C:neuronal cell body; C:postsynaptic membrane; C:presynaptic active zone; C:presynaptic membrane; C:protein-containing complex; C:receptor complex; C:rough endoplasmic reticulum; C:synapse; C:terminal bouton;	  F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:calcium channel regulator activity; F:calcium-dependent protein binding; F:calmodulin binding; F:glutamate binding; F:glutamate receptor activity; F:group III metabotropic glutamate receptor activity; F:identical protein binding; F:PDZ domain binding; F:serine binding; F:voltage-gated calcium channel activity;	  P:adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway; P:adult behavior; P:associative learning; P:behavioral fear response; P:chemical synaptic transmission; P:conditioned taste aversion; P:G protein-coupled glutamate receptor signaling pathway; P:learning or memory; P:memory; P:multicellular organismal response to stress; P:negative regulation of glutamate secretion; P:negative regulation of neuron apoptotic process; P:nervous system process; P:regulation of synaptic transmission, glutamatergic; P:regulation of synaptic vesicle exocytosis; P:sensory perception of sound; P:short-term memory; P:transmission of nerve impulse;
XM_040203130.1	chrXVII	1044468	1044468	chrXVII	1041419	1045316	+	XM_040203130.1	path1	Q8NCE0 B7Z6K1 C9IZI7 G5E9Q3 Q8WTW7 Q9BPU7	tRNA-splicing endonuclease subunit Sen2	tRNA-intron endonuclease Sen2;	 PF01974;PF02778;	 GO:0005813;GO:0005829;GO:0005730;GO:0005654;GO:0000214;GO:0016829;GO:0003676;GO:0000213;GO:0006397;GO:0006388;GO:0000379;	  C:centrosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;	  F:lyase activity; F:nucleic acid binding; F:tRNA-intron endonuclease activity;	  P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage;
XM_040203128.1	chrXVII	1044468	1044468	chrXVII	1045492	1050094	+	XM_040203128.1	path1	Q5RC80	RNA-binding protein 39	RNA-binding motif protein 39;	 PF15519;PF00076;	 GO:0016607;GO:0003723;GO:0006397;GO:0048024;GO:0008380;	  C:nuclear speck;	  F:RNA binding;	  P:mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing;
XM_040204562.1	chrXVII	5791216	5791216	chrXVII	5786941	5826078	+	XM_040204562.1	path1	Q91690	Zinc finger protein GLI1		 PF00096;	 GO:0005737;GO:0005634;GO:0003682;GO:0046872;GO:0000977;GO:0043565;GO:0030154;GO:0021983;GO:0045893;GO:0006357;GO:0007224;	  C:cytoplasm; C:nucleus;	  F:chromatin binding; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;	  P:cell differentiation; P:pituitary gland development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:smoothened signaling pathway;
XM_040161196.1	chrXVIII	13683310	13683310	chrXVIII	13608801	13696867	-	XM_040161196.1	path1	Q13950 O14614 O14615 O95181	Runt-related transcription factor 2	Acute myeloid leukemia 3 protein;Core-binding factor subunit alpha-1;Oncogene AML-3;Osteoblast-specific transcription factor 2;Polyomavirus enhancer-binding protein 2 alpha A subunit;SL3-3 enhancer factor 1 alpha A subunit;SL3/AKV core-binding factor alpha A subunit;	 PF00853;PF08504;	 GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030509;GO:0071773;GO:0002062;GO:0030097;GO:0045892;GO:0030182;GO:0001503;GO:0001649;GO:0045669;GO:0045944;GO:1901522;GO:0045893;GO:0045595;GO:0006357;GO:0060260;	  C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;	  F:ATP binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:BMP signaling pathway; P:cellular response to BMP stimulus; P:chondrocyte differentiation; P:hemopoiesis; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:ossification; P:osteoblast differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;
XM_040161198.1	chrXVIII	13683310	13683310	chrXVIII	13608801	13696869	-	XM_040161198.1	path1	Q13761 B1AJV5 Q12969 Q13760	Runt-related transcription factor 3	Acute myeloid leukemia 2 protein;Core-binding factor subunit alpha-3;Oncogene AML-2;Polyomavirus enhancer-binding protein 2 alpha C subunit;SL3-3 enhancer factor 1 alpha C subunit;SL3/AKV core-binding factor alpha C subunit;	 PF00853;PF08504;	 GO:0000785;GO:0016513;GO:0005737;GO:0005829;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003700;GO:0000981;GO:0000978;GO:0000977;GO:1990837;GO:0002062;GO:0030097;GO:0043371;GO:0045786;GO:0050680;GO:0000122;GO:0030182;GO:0001503;GO:0048935;GO:0043378;GO:0045893;GO:0006468;GO:0045595;GO:0006357;GO:0006355;GO:0071559;	  C:chromatin; C:core-binding factor complex; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;	  F:ATP binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:chondrocyte differentiation; P:hemopoiesis; P:negative regulation of CD4-positive, alpha-beta T cell differentiation; P:negative regulation of cell cycle; P:negative regulation of epithelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:ossification; P:peripheral nervous system neuron development; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to transforming growth factor beta;
XM_040161199.1	chrXVIII	13693061	13693061	chrXVIII	13695635	13703482	+	XM_040161199.1	path1	Q6U736 A0AV33 Q5T5B9 Q5T886 Q7Z603 Q86SL5	Opsin-5	G-protein coupled receptor 136;G-protein coupled receptor PGR12;Neuropsin;Transmembrane protein 13;	 PF00001;	 GO:0005737;GO:0005887;GO:0005886;GO:0005502;GO:0008020;GO:0071482;GO:0071492;GO:0043153;GO:0007186;GO:1990384;GO:0007602;GO:0007604;GO:0018298;GO:0007601;	  C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;	  F:11-cis retinal binding; F:G protein-coupled photoreceptor activity;	  P:cellular response to light stimulus; P:cellular response to UV-A; P:entrainment of circadian clock by photoperiod; P:G protein-coupled receptor signaling pathway; P:hyaloid vascular plexus regression; P:phototransduction; P:phototransduction, UV; P:protein-chromophore linkage; P:visual perception;
XM_040160823.1	chrXVIII	13777410	13777410	chrXVIII	13753215	13797485	+	XM_040160823.1	path1	Q9ULI0 B9ZVQ5 Q6ZNA6 Q8N9E7	ATPase family AAA domain-containing protein 2B		 PF00004;PF17862;PF00439;	 GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0042393;GO:0070577;GO:0031936;GO:0045944;	  C:nucleoplasm; C:nucleus;	  F:ATP binding; F:ATPase activity; F:chromatin binding; F:histone binding; F:lysine-acetylated histone binding;	  P:negative regulation of chromatin silencing; P:positive regulation of transcription by RNA polymerase II;
XM_040165028.1	chrXX	4654736	4654736	chrXX	4649714	4656157	-	XM_040165028.1	path1	Q63054 Q6P3W0	Islet cell autoantigen 1	69 kDa islet cell autoantigen;Islet cell autoantigen p69;	 PF06456;PF04629;	 GO:0005829;GO:0030425;GO:0005794;GO:0000139;GO:0005795;GO:0048471;GO:0030667;GO:0030672;GO:0140090;GO:0019904;GO:0006836;GO:0050796;GO:0043254;GO:0051049;	  C:cytosol; C:dendrite; C:Golgi apparatus; C:Golgi membrane; C:Golgi stack; C:perinuclear region of cytoplasm; C:secretory granule membrane; C:synaptic vesicle membrane;	  F:membrane curvature sensor activity; F:protein domain specific binding;	  P:neurotransmitter transport; P:regulation of insulin secretion; P:regulation of protein-containing complex assembly; P:regulation of transport;
XM_040164405.1	chrXX	4729827	4729827	chrXX	4675260	4768840	-	XM_040164405.1	path1	A7MBS7 E3VW06 F1QPE6	Thrombospondin type-1 domain-containing protein 7A		 PF19028;PF00090;	 GO:0042995;GO:0016021;GO:0005886;GO:0031532;GO:0001525;GO:0048675;GO:0043534;GO:0003094;GO:0072015;GO:0032835;GO:0008593;GO:0002040;	  C:cell projection; C:integral component of membrane; C:plasma membrane;	 	  P:actin cytoskeleton reorganization; P:angiogenesis; P:axon extension; P:blood vessel endothelial cell migration; P:glomerular filtration; P:glomerular visceral epithelial cell development; P:glomerulus development; P:regulation of Notch signaling pathway; P:sprouting angiogenesis;
XM_040164408.1	chrXX	4794604	4794604	chrXX	4786534	4791723	+	XM_040164408.1	path1	Q1LWC2 Q1LYK6	Transmembrane protein 106B		 PF07092;	 GO:0016021;GO:0031902;GO:0005765;GO:0048813;GO:0032418;	  C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane;	 	  P:dendrite morphogenesis; P:lysosome localization;
XM_040164409.1	chrXX	4794604	4794604	chrXX	4793904	4796991	+	XM_040164409.1	path1	Q8N2E2 B7ZM77 Q96SQ3	von Willebrand factor D and EGF domain-containing protein		 PF00094;	 GO:0009986;GO:0005576;GO:0005102;GO:0048856;	  C:cell surface; C:extracellular region;	  F:signaling receptor binding;	  P:anatomical structure development;
XM_040166432.1	chrXX	10174287	10174287	chrXX	10129068	10195827	+	XM_040166432.1	path1	Q76LL6 B2RQR3 Q5DTV7 Q76HP7 Q76LL5	FH1/FH2 domain-containing protein 3	Formin homolog overexpressed in spleen 2;	 PF02181;PF18382;	 GO:0005737;GO:0005856;GO:0030017;GO:0005865;GO:0030018;GO:0051015;GO:0051639;GO:0055003;GO:0030866;GO:0030837;GO:0045214;	  C:cytoplasm; C:cytoskeleton; C:sarcomere; C:striated muscle thin filament; C:Z disc;	  F:actin filament binding;	  P:actin filament network formation; P:cardiac myofibril assembly; P:cortical actin cytoskeleton organization; P:negative regulation of actin filament polymerization; P:sarcomere organization;
XM_040166373.1	chrXX	10242975	10242975	chrXX	10227618	10234296	+	XM_040166373.1	path1	P10039 O73584 O73585 P13132	Tenascin	Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;	 PF07974;PF18720;PF00147;PF00041;	 GO:0062023;GO:0005615;GO:0005102;GO:0007155;GO:0042127;	  C:collagen-containing extracellular matrix; C:extracellular space;	  F:signaling receptor binding;	  P:cell adhesion; P:regulation of cell population proliferation;
XM_040166091.1	chrXX	10242975	10242975	chrXX	10234536	10237797	+	XM_040166091.1	path1	P08686 A2BHY6 P04033 Q01204 Q08AG8 Q16749 Q16806 Q5ST44 Q96NU8	Steroid 21-hydroxylase {ECO:0000303|PubMed:25855791}	21-OHase;Cytochrome P-450c21;Cytochrome P450 21;Cytochrome P450 XXI;Cytochrome P450-C21;Cytochrome P450-C21B;	 PF00067;	 GO:0005789;GO:0103069;GO:0020037;GO:0005506;GO:0106309;GO:0004509;GO:0005496;GO:0008395;GO:0006704;GO:0006705;GO:0006694;GO:0008202;GO:0016125;	  C:endoplasmic reticulum membrane;	  F:17-hydroxyprogesterone 21-hydroxylase activity; F:heme binding; F:iron ion binding; F:progesterone 21-hydroxylase activity; F:steroid 21-monooxygenase activity; F:steroid binding; F:steroid hydroxylase activity;	  P:glucocorticoid biosynthetic process; P:mineralocorticoid biosynthetic process; P:steroid biosynthetic process; P:steroid metabolic process; P:sterol metabolic process;
XM_040165609.1	chrXX	10242975	10242975	chrXX	10243848	10245316	+	XM_040165609.1	path1	Q9BQI0 B2RBC4 Q6ZR40 Q8NAX7 Q8WU47 Q9H9G0	Allograft inflammatory factor 1-like	Ionized calcium-binding adapter molecule 2;	 	 GO:0015629;GO:0005737;GO:0070062;GO:0005925;GO:0032991;GO:0032587;GO:0051015;GO:0005509;GO:0051017;GO:0097178;	  C:actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:protein-containing complex; C:ruffle membrane;	  F:actin filament binding; F:calcium ion binding;	  P:actin filament bundle assembly; P:ruffle assembly;
XR_005710264.1	chrXX	10242975	10242975	chrXX	10244982	10267375	-	XR_005710264.1	path1	Q9N179	Protein 4.1	4.1R;Band 4.1;Erythrocyte membrane protein band 4.1 {ECO:0000250|UniProtKB:P11171};	 PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;	 GO:0016323;GO:0099738;GO:0005856;GO:0005634;GO:0005886;GO:0003779;GO:0005516;GO:0005198;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:1904778;GO:0051924;GO:1904478;	  C:basolateral plasma membrane; C:cell cortex region; C:cytoskeleton; C:nucleus; C:plasma membrane;	  F:actin binding; F:calmodulin binding; F:structural molecule activity;	  P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein localization to cell cortex; P:regulation of calcium ion transport; P:regulation of intestinal absorption;
XM_040165608.1	chrXX	10242975	10242975	chrXX	10245423	10248902	+	XM_040165608.1	path1	P67868 P07312 P13862 Q2YDL2	Casein kinase II subunit beta	Phosvitin;	 PF01214;	 GO:0005737;GO:0005956;GO:0046872;GO:0019887;GO:0046719;GO:0042325;GO:0050792;GO:0016055;	  C:cytoplasm; C:protein kinase CK2 complex;	  F:metal ion binding; F:protein kinase regulator activity;	  P:regulation by virus of viral protein levels in host cell; P:regulation of phosphorylation; P:regulation of viral process; P:Wnt signaling pathway;
XM_040165999.1	chrXX	15025837	15025837	chrXX	15019912	15055674	+	XM_040165999.1	path1	Q9UL36 B2RTX9 Q9UL37	Zinc finger protein 236		 PF00096;	 GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0071333;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II;
XM_040165080.1	chrXX	19390057	19390057	chrXX	19332260	19425265	+	XM_040165080.1	path1	F1NTD6	Activating signal cointegrator 1 complex subunit 3		 PF00270;PF00271;PF02889;	 GO:0099053;GO:0005829;GO:0016607;GO:0005634;GO:0043138;GO:0005524;GO:0003723;GO:0008283;GO:0006307;GO:0032508;	  C:activating signal cointegrator 1 complex; C:cytosol; C:nuclear speck; C:nucleus;	  F:3'-5' DNA helicase activity; F:ATP binding; F:RNA binding;	  P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA duplex unwinding;
XM_040166262.1	chrXX	19409964	19409964	chrXX	19428445	19446622	+	XM_040166262.1	path1	Q98SJ5	Single-minded homolog 1-A		 PF00989;PF08447;PF06621;	 GO:0005634;GO:0000981;GO:0046983;GO:0000977;GO:0007411;GO:0021536;GO:0071542;GO:0021979;GO:0035776;GO:0048793;GO:0072020;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;	  P:axon guidance; P:diencephalon development; P:dopaminergic neuron differentiation; P:hypothalamus cell differentiation; P:pronephric proximal tubule development; P:pronephros development; P:proximal straight tubule development; P:regulation of transcription by RNA polymerase II;
XM_040164938.1	chrXX	19499934	19499934	chrXX	19505160	19513686	+	XM_040164938.1	path1	Q502I6	Cytochrome b5 reductase 4	Flavohemoprotein b5/b5R;cb5/cb5R;	 PF00173;PF00970;PF00175;	 GO:0005783;GO:0004128;GO:0020037;GO:0046872;GO:0006091;GO:0006801;	  C:endoplasmic reticulum;	  F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:heme binding; F:metal ion binding;	  P:generation of precursor metabolites and energy; P:superoxide metabolic process;
XM_040164940.1	chrXX	19499934	19499934	chrXX	19515588	19527495	-	XM_040164940.1	path1	Q08CN9	E3 ubiquitin-protein ligase znrf2	RING-type E3 ubiquitin transferase znrf2;Zinc/RING finger protein 2;	 PF13639;	 GO:0042995;GO:0010008;GO:0005765;GO:0042734;GO:0046872;GO:0016740;GO:0016567;	  C:cell projection; C:endosome membrane; C:lysosomal membrane; C:presynaptic membrane;	  F:metal ion binding; F:transferase activity;	  P:protein ubiquitination;
XM_040164140.1	chrXX	19550962	19550962	chrXX	19543349	19545204	+	XM_040164140.1	path1	P79762 Q4VU46 Q4VU49 Q4VU50 Q4VU53 Q4VU54 Q4VU57 Q4VU62 Q4VU63 Q4VU66 Q9PWF8	Zona pellucida sperm-binding protein 3	Sperm receptor;Zona pellucida C protein;Zona pellucida glycoprotein 3;	 PF00100;	 GO:0045177;GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0032190;GO:0042802;GO:0035804;GO:0007339;GO:0035803;GO:2000344;GO:0032570;GO:0033574;	  C:apical part of cell; C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;	  F:acrosin binding; F:identical protein binding; F:structural constituent of egg coat;	  P:binding of sperm to zona pellucida; P:egg coat formation; P:positive regulation of acrosome reaction; P:response to progesterone; P:response to testosterone;
XM_040166987.1	chrXXI	12285135	12285135	chrXXI	12280554	12285046	+	XM_040166987.1	path1	Q6A4L0 E9QP74 Q8VC89	Solute carrier family 22 member 13	Organic cation transporter-like 3;	 PF00083;	 GO:0016324;GO:0005783;GO:0005794;GO:0016021;GO:0005886;GO:0090416;GO:0045922;GO:2001142;GO:0002854;GO:0015747;	  C:apical plasma membrane; C:endoplasmic reticulum; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;	  F:nicotinate transmembrane transporter activity;	  P:negative regulation of fatty acid metabolic process; P:nicotinate transport; P:positive regulation of T cell mediated cytotoxicity directed against tumor cell target; P:urate transport;
XM_040166983.1	chrXXI	12285135	12285135	chrXXI	12287700	12294726	-	XM_040166983.1	path1	Q5PZ43	Xin actin-binding repeat-containing protein 1	Cardiomyopathy-associated protein 1;	 PF08043;	 GO:0030054;GO:0003779;GO:0030036;	  C:cell junction;	  F:actin binding;	  P:actin cytoskeleton organization;
XM_040167479.1	chrXXI	15917415	15917415	chrXXI	15902388	15945215	-	XM_040167479.1	path1	Q13634 A8K0I2 B4DHG6 Q8N5Z2	Cadherin-18	Cadherin-14;	 PF00028;PF01049;	 GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;	  C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;	  F:cadherin binding; F:calcium ion binding;	  P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development;
XM_040167583.1	chrXXI	16079787	16079787	chrXXI	16040433	16110337	-	XM_040167583.1	path1	P55289 B2RBT1 B7Z2U6 Q86UD2	Cadherin-12	Brain cadherin;Neural type cadherin 2;	 PF00028;PF01049;	 GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;	  C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;	  F:cadherin binding; F:calcium ion binding;	  P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development;
